Background	Background	NNP	B-NP
Cytosolic	Cytosolic	NNP	I-NP
PLA	PLA	NNP	I-NP
2	2	CD	0
specifically	specifically	CD	0
sn-2	sn-2	CD	B-NP
arachidonate	arachidonate	NN	I-NP
hydrolyz	hydrolyz	NN	I-NP
from	from	IN	0
phospholipid	phospholipid	NN	B-NP
providing	providing	VBG	0
the	the	DT	0
precursors	precursors	NN	0
for	for	IN	0
many	many	JJ	0
different	different	JJ	0
including	including	VBG	B-NP
prostaglandin	prostaglandin	NN	I-NP
lipid	lipid	NNS	I-NP
mediator	mediator	NN	I-NP
and	and	CC	0
leukotriene	leukotriene	NN	B-NP
[	[	-LRB-	0
1	1	CD	0
2	2	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
lipid	lipid	JJ	B-NP
metabolite	metabolite	NN	I-NP
play	play	VBP	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
acute	acute	JJ	0
inflammatory	inflammatory	JJ	B-NP
response	response	NN	I-NP
and	and	CC	0
also	also	RB	0
regulate	regulate	VB	0
normal	normal	JJ	B-NP
physiological	physiological	JJ	I-NP
process	process	NN	I-NP
.	.	.	0
certain	certain	JJ	B-NP
prostaglandin	prostaglandin	NN	I-NP
are	are	VBP	0
required	required	VBN	0
for	for	IN	0
female	female	JJ	0
reproduction	reproduction	NN	B-NP
and	and	CC	0
kidney	kidney	NN	0
function	function	NN	0
[	[	-LRB-	0
3	3	CD	0
4	4	CD	0
5	5	CD	0
]	]	-RRB-	0
.	.	.	0
Because	Because	IN	0
of	of	IN	0
its	its	PRP$	0
important	important	JJ	0
role	role	NN	0
in	in	IN	0
arachidonic	arachidonic	JJ	B-NP
acid	acid	NN	I-NP
controlling	controlling	VBG	I-NP
level	level	JJ	I-NP
(	(	-LRB-	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
)	)	-RRB-	0
,	,	,	0
much	much	JJ	0
attention	attention	NN	0
has	has	VBZ	0
been	been	VBN	0
focused	focused	VBN	0
on	on	IN	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
activation	activation	NN	B-NP
,	,	,	0
with	with	IN	0
particular	particular	JJ	0
emphasis	emphasis	NN	0
on	on	IN	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
its	its	PRP$	0
phosphorylation	phosphorylation	NN	B-NP
and	and	CC	0
Ca	Ca	NNP	B-NP
2+-mediated	2+-mediated	FW	0
translocation	translocation	NN	B-NP
[	[	-LRB-	0
6	6	CD	0
7	7	CD	0
8	8	CD	0
]	]	-RRB-	0
.	.	.	0
cPLA	cPLA	SYM	B-NP
2	2	CD	0
is	is	VBZ	0
regulated	regulated	VBN	0
by	by	IN	0
controlling	controlling	VBG	0
its	its	PRP$	0
cellular	cellular	JJ	B-NP
localization	localization	NN	I-NP
and	and	CC	0
access	access	NN	0
to	to	TO	0
membrane-phospholipid	membrane-phospholipid	JJ	B-NP
substrate	substrate	NN	I-NP
.	.	.	0
An	An	DT	0
amino	amino	JJ	0
terminal	terminal	NN	0
,	,	,	0
calcium-dependent	calcium-dependent	JJ	B-NP
lipid	lipid	NN	I-NP
binding	binding	NNS	0
(	(	-LRB-	0
CaLB	CaLB	NNP	B-NP
or	or	CC	0
C2	C2	CD	0
)	)	-RRB-	0
domain	domain	NN	0
regulates	regulates	VBZ	0
Ca	Ca	NNP	B-NP
2+-mediated	2+-mediated	NNP	0
cPLA	cPLA	NNP	B-NP
2	2	CD	0
translocation	translocation	NN	B-NP
to	to	TO	0
intracellular	intracellular	VB	0
membranes	membranes	NNS	0
[	[	-LRB-	0
9	9	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
vitro	vitro	NN	B-NP
,	,	,	0
membrane	membrane	JJ	0
docking	docking	NN	0
via	via	IN	0
the	the	DT	0
C2	C2	JJ	B-NP
domain	domain	NN	I-NP
is	is	VBZ	0
necessary	necessary	JJ	0
and	and	CC	0
sufficient	sufficient	JJ	0
for	for	IN	0
catalysis	catalysis	NN	0
and	and	CC	0
release	release	NN	0
of	of	IN	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
[	[	-LRB-	0
10	10	CD	0
]	]	-RRB-	0
.	.	.	0
Binding	Binding	VBG	0
of	of	IN	0
calcium	calcium	JJ	0
ions	ions	NN	0
by	by	IN	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
C2	C2	CD	B-NP
domain	domain	NN	I-NP
is	is	VBZ	0
essential	essential	JJ	0
for	for	IN	0
the	the	DT	0
lipid	lipid	JJ	B-NP
association	association	NN	I-NP
in	in	IN	0
vitro	vitro	NN	B-NP
[	[	-LRB-	0
11	11	CD	0
12	12	CD	0
]	]	-RRB-	0
and	and	CC	0
translocation	translocation	NN	B-NP
in	in	IN	0
vivo	vivo	NN	B-NP
[	[	-LRB-	0
13	13	CD	0
14	14	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
response	response	NN	0
to	to	TO	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
,	,	,	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocate	translocate	NN	B-NP
to	to	TO	0
the	the	DT	0
Golgi	Golgi	NNP	B-NP
and	and	CC	0
endoplasmic	endoplasmic	NN	B-NP
reticulum	reticulum	NN	I-NP
,	,	,	0
however	however	RB	0
translocation	translocation	VBN	0
to	to	TO	0
Golgi	Golgi	NNP	B-NP
occurs	occurs	VBZ	0
at	at	IN	0
a	a	DT	0
lower	lower	JJR	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
protein	protein	NN	B-NP
kinase	kinase	NN	I-NP
pathway	pathway	NN	I-NP
play	play	VBP	0
major	major	JJ	0
roles	roles	NNS	0
in	in	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
activation	activation	NN	B-NP
,	,	,	0
and	and	CC	0
regulation	regulation	NN	0
by	by	IN	0
the	the	DT	0
mitogen-activated	mitogen-activated	JJ	B-NP
protein	protein	NN	I-NP
kinase	kinase	NN	I-NP
kinasa	kinasa	NN	I-NP
(	(	-LRB-	0
MEK	MEK	NNP	B-NP
)	)	-RRB-	0
/	/	FW	0
regulated	regulated	VBN	B-NP
kinase	kinase	NN	I-NP
extracellular-signal	extracellular-signal	NN	I-NP
(	(	-LRB-	0
extracellular-signal	extracellular-signal	NN	B-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
)	)	-RRB-	0
signaling	signaling	VBG	B-NP
pathway	pathway	NN	I-NP
has	has	VBZ	0
received	received	VBN	0
particular	particular	JJ	0
attention.	attention.	NNP	0
cPLA	cPLA	NNP	B-NP
2	2	CD	0
is	is	VBZ	0
phosphorylated	phosphorylated	VBN	0
by	by	IN	0
mitogen	mitogen	JJ	B-NP
activated	activated	JJ	I-NP
protein	protein	NN	I-NP
(	(	-LRB-	0
mitogen	mitogen	NN	B-NP
activated	activated	VBN	I-NP
protein	protein	NN	I-NP
)	)	-RRB-	0
kinas	kinas	NNP	B-NP
,	,	,	0
including	including	VBG	B-NP
p42	p42	NNP	I-NP
/	/	NNP	0
p44	p44	NNP	B-NP
erk	erk	NN	I-NP
and	and	CC	0
p38	p38	NNP	B-NP
,	,	,	0
on	on	IN	0
Ser	Ser	NNP	0
505in	505in	FW	0
vitro	vitro	FW	0
[	[	-LRB-	0
16	16	CD	0
17	17	CD	0
]	]	-RRB-	0
and	and	CC	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
receptor	receptor	VB	0
stimulation	stimulation	NNS	0
[	[	-LRB-	0
16	16	CD	0
18	18	CD	0
19	19	CD	0
20	20	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
addition	addition	NN	0
to	to	TO	0
phosphorylation	phosphorylation	VB	0
by	by	IN	0
MAP	MAP	NNP	B-NP
kinase	kinase	NN	I-NP
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
that	that	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
is	is	VBZ	0
also	also	RB	0
phosphorylated	phosphorylated	VBN	0
on	on	IN	0
Ser	Ser	NNP	0
727by	727by	NNP	0
MAPK-interacting	MAPK-interacting	NNP	0
kinase	kinase	VBD	0
I	I	PRP	0
(	(	-LRB-	0
MNKI	MNKI	NNP	B-NP
)	)	-RRB-	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
and	and	CC	0
on	on	IN	0
Ser	Ser	NNP	0
515by	515by	FW	0
calcium	calcium	FW	0
/	/	FW	0
calmodulin-dependent	calmodulin-dependent	FW	0
protein	protein	FW	0
kinase	kinase	FW	0
II	II	NNP	0
[	[	-LRB-	0
23	23	CD	0
]	]	-RRB-	0
.	.	.	0
Phosphorylation	Phosphorylation	NNP	B-NP
of	of	IN	0
these	these	DT	0
sites	sites	NNS	0
may	may	MD	0
also	also	RB	0
play	play	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
regulating	regulating	VBG	0
cPLA	cPLA	JJ	0
2	2	CD	0
function	function	NN	0
in	in	IN	0
certain	certain	JJ	0
cell	cell	NN	0
models	models	NNS	0
.	.	.	0
Phosphorylation	Phosphorylation	NNP	B-NP
of	of	IN	0
Ser	Ser	NNP	0
505has	505has	VBZ	0
been	been	VBN	0
extensively	extensively	RB	0
studied	studied	VBN	0
because	because	IN	0
it	it	PRP	0
is	is	VBZ	0
readily	readily	RB	0
detected	detected	VBN	0
due	due	JJ	0
to	to	TO	0
a	a	DT	0
characteristic	characteristic	JJ	B-NP
electrophoretic	electrophoretic	JJ	I-NP
mobility	mobility	JJ	I-NP
shift	shift	NN	I-NP
when	when	WRB	0
analyzed	analyzed	VBN	0
by	by	IN	0
SDS-PAGE	SDS-PAGE	NNP	B-NP
[	[	-LRB-	0
13	13	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
importance	importance	NN	0
of	of	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
in	in	IN	0
regulating	regulating	VBG	0
cPLA	cPLA	JJ	0
2	2	CD	0
has	has	VBZ	0
been	been	VBN	0
demonstrated	demonstrated	VBN	0
in	in	IN	0
different	different	JJ	0
cells	cells	NNS	0
and	and	CC	0
in	in	IN	0
vitro	vitro	JJ	B-NP
model	model	NN	I-NP
by	by	IN	0
using	using	VBG	0
cPLA	cPLA	JJ	0
2	2	CD	0
containing	containing	VBG	0
a	a	DT	0
S505A	S505A	JJ	0
mutation	mutation	NN	0
[	[	-LRB-	0
16	16	CD	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
the	the	DT	0
mechanism	mechanism	NN	0
whereby	whereby	WRB	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
regulates	regulates	VBZ	0
cPLA	cPLA	JJ	0
2	2	CD	0
function	function	NN	0
has	has	VBZ	0
been	been	VBN	0
elusive	elusive	JJ	0
.	.	.	0
In	In	IN	0
vitro	vitro	JJ	B-NP
study	study	NN	I-NP
have	have	VBP	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
dephosphorylated	dephosphorylated	JJ	B-NP
cPLA	cPLA	JJ	I-NP
2	2	CD	0
is	is	VBZ	0
catalytically	catalytically	JJ	0
active	active	JJ	0
and	and	CC	0
that	that	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
increases	increases	VBZ	0
activity	activity	NN	0
by	by	IN	0
only	only	RB	0
~30	~30	CD	0
percent	percent	NN	0
[	[	-LRB-	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
cells	cells	NNS	0
expressing	expressing	VBG	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
mutation	mutation	NNS	0
fail	fail	VBP	0
to	to	TO	0
release	release	VB	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
a	a	DT	0
low	low	JJ	0
dose	dose	NN	0
of	of	IN	0
calcium	calcium	JJ	B-NP
ionophore	ionophore	NN	I-NP
,	,	,	0
but	but	CC	0
release	release	VB	0
similar	similar	JJ	0
amounts	amounts	NNS	0
of	of	IN	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
as	as	IN	0
cells	cells	NNS	0
expressing	expressing	VBG	B-NP
wild-type	wild-type	JJ	I-NP
cPLA	cPLA	JJ	0
2	2	CD	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
high	high	JJ	0
dose	dose	NN	B-NP
ionophora	ionophora	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
From	From	IN	0
these	these	DT	0
studies	studies	NNS	0
,	,	,	0
it	it	PRP	0
has	has	VBZ	0
been	been	VBN	0
suggested	suggested	VBN	0
that	that	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
may	may	MD	0
have	have	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
regulating	regulating	VBG	B-NP
translocation	translocation	NN	I-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
A	A	DT	0
previous	previous	JJ	0
study	study	NN	0
demonstrated	demonstrated	VBD	0
translocation	translocation	VBN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
Ca	Ca	NNP	B-NP
2+ionophore	2+ionophore	NNP	0
,	,	,	0
but	but	CC	0
did	did	VBD	0
not	not	RB	0
address	address	VB	0
the	the	DT	0
kinetics	kinetics	NN	0
of	of	IN	0
translocation	translocation	NN	B-NP
,	,	,	0
translocation	translocation	VBG	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
a	a	DT	0
physiological	physiological	JJ	B-NP
agonist	agonist	NN	I-NP
,	,	,	0
or	or	CC	0
differences	differences	NNS	0
in	in	IN	0
targeting	targeting	VBG	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
better	better	RB	0
understand	understand	VB	0
the	the	DT	0
regulation	regulation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
by	by	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
and	and	CC	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
,	,	,	0
we	we	PRP	0
investigated	investigated	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
mek	mek	NN	B-NP
inhibitor	inhibitor	NN	I-NP
on	on	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
,	,	,	0
cPLA	cPLA	JJ	0
2	2	CD	0
phosphorylation	phosphorylation	NN	B-NP
of	of	IN	0
Ser	Ser	NNP	0
505	505	CD	0
,	,	,	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	JJ	B-NP
kinetics	kinetics	NN	I-NP
,	,	,	0
and	and	CC	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
in	in	IN	0
Madin-Darby	Madin-Darby	JJ	B-NP
canine	canine	JJ	I-NP
kidney	kidney	NN	I-NP
(	(	-LRB-	0
madin-darby	madin-darby	NN	B-NP
canine	canine	JJ	I-NP
kidney	kidney	NN	I-NP
)	)	-RRB-	0
cells	cells	NNS	0
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
MEK1	MEK1	CD	B-NP
by	by	IN	0
U0126	U0126	NNP	0
significantly	significantly	RB	0
inhibited	inhibited	JJ	0
AA	AA	NN	B-NP
release	release	NN	I-NP
and	and	CC	0
this	this	DT	0
was	was	VBD	0
correlated	correlated	VBN	0
with	with	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
.	.	.	0
However	However	RB	0
,	,	,	0
MEK	MEK	NNP	B-NP
inhibition	inhibition	VBD	I-NP
only	only	RB	0
partially	partially	RB	0
affected	affected	VBN	0
cPLA	cPLA	JJ	0
2	2	CD	0
phosphorylation	phosphorylation	NN	B-NP
and	and	CC	0
had	had	VBD	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
the	the	DT	0
kinetics	kinetics	NN	0
of	of	IN	0
Ca	Ca	NNP	B-NP
2+-mediated	2+-mediated	NNP	0
cPLA	cPLA	NNP	B-NP
2	2	CD	0
translocation	translocation	NN	B-NP
to	to	TO	0
membrane	membrane	VB	0
.	.	.	0
In	In	IN	0
addition	addition	NN	B-NP
,	,	,	0
using	using	VBG	0
cells	cells	NNS	0
expressing	expressing	VBG	B-NP
wild-type	wild-type	JJ	I-NP
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
with	with	IN	0
S505A	S505A	NNP	0
or	or	CC	0
S727A	S727A	CD	0
mutations	mutations	NNS	0
,	,	,	0
it	it	PRP	0
was	was	VBD	0
found	found	VBN	0
that	that	IN	0
translocation	translocation	JJ	B-NP
kinetics	kinetics	NN	I-NP
and	and	CC	0
membrane	membrane	VBP	0
targeting	targeting	VBG	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
ATP	ATP	NNP	B-NP
or	or	CC	0
ionomycin	ionomycin	NN	B-NP
was	was	VBD	0
similar	similar	JJ	0
to	to	TO	0
wild-type	wild-type	JJ	B-NP
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
These	These	DT	0
data	data	NNS	0
suggest	suggest	VBP	0
that	that	IN	0
MEK1	MEK1	CD	B-NP
inhibition	inhibition	NN	I-NP
reduces	reduces	VBZ	0
cPLA	cPLA	JJ	0
2	2	CD	0
catalytic	catalytic	JJ	B-NP
activity	activity	NN	I-NP
and	and	CC	0
AA	AA	NN	B-NP
release	release	NN	I-NP
independently	independently	RB	0
of	of	IN	0
phosphorylation	phosphorylation	NN	B-NP
and	and	CC	0
translocation	translocation	NN	B-NP
.	.	.	0
Results	Results	NNS	0
Effect	Effect	NN	0
of	of	IN	0
MEK	MEK	NNP	B-NP
inhibition	inhibition	NN	I-NP
on	on	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
,	,	,	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
cPLA	cPLA	JJ	0
2Ser	2Ser	CD	0
505phosphorylation	505phosphorylation	CD	0
To	To	TO	0
study	study	VB	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
in	in	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
activation	activation	NN	B-NP
,	,	,	0
quiesced	quiesced	JJ	B-NP
mdck	mdck	NN	I-NP
cell	cell	NN	I-NP
were	were	VBD	0
treated	treated	VBN	0
with	with	IN	0
the	the	DT	0
MEK1	MEK1	CD	B-NP
inhibitor	inhibitor	CD	I-NP
U0126	U0126	CD	0
,	,	,	0
and	and	CC	0
the	the	DT	0
effect	effect	NN	0
on	on	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
,	,	,	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
,	,	,	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
gel	gel	NN	B-NP
shift	shift	VBP	0
determined	determined	VBN	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
1	1	CD	0
)	)	-RRB-	0
.	.	.	0
For	For	IN	0
equivalence	equivalence	NN	0
with	with	IN	0
the	the	DT	0
imaging	imaging	JJ	0
studies	studies	NNS	0
,	,	,	0
cells	cells	NNS	0
expressing	expressing	VBG	B-NP
EGFP-cPLA	EGFP-cPLA	JJ	I-NP
2	2	CD	0
were	were	VBD	0
used	used	VBN	0
in	in	IN	0
all	all	DT	0
experiments	experiments	NNS	0
.	.	.	0
EGFP-cPLA	EGFP-cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
expressed	expressed	VBN	0
to	to	TO	0
similar	similar	JJ	0
levels	levels	NNS	0
as	as	IN	0
endogenous	endogenous	JJ	0
enzyme	enzyme	NN	0
but	but	CC	0
did	did	VBD	0
not	not	RB	0
contribute	contribute	VB	0
significantly	significantly	RB	0
to	to	TO	0
AA	AA	NN	0
release	release	NN	0
in	in	IN	0
stably	stably	JJ	0
transfected	transfected	JJ	0
cells	cells	NNS	0
.	.	.	0
However	However	RB	0
,	,	,	0
EGFP-cPLA	EGFP-cPLA	JJ	0
2	2	CD	0
is	is	VBZ	0
functional	functional	VBN	0
since	since	IN	0
it	it	PRP	0
dose-dependently	dose-dependently	JJ	0
catalyzes	catalyzes	JJ	0
release	release	NN	0
of	of	IN	0
AA	AA	NN	0
when	when	WRB	0
expressed	expressed	VBN	0
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
lack	lack	VBP	0
endogenous	endogenous	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
,	,	,	0
such	such	JJ	0
as	as	IN	0
Sf9	Sf9	CD	0
cells	cells	NNS	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
and	and	CC	0
immortalized	immortalized	JJ	0
mouse	mouse	NN	0
lung	lung	NN	0
fibroblasts	fibroblasts	NN	0
from	from	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
α	α	CD	0
knock-out	knock-out	JJ	0
mice	mice	NNS	0
[	[	-LRB-	0
26	26	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
enhance	enhance	VB	0
AA	AA	NN	0
release	release	NN	0
in	in	IN	0
cells	cells	NNS	0
containing	containing	VBG	0
endogenous	endogenous	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
necessary	necessary	JJ	0
to	to	TO	0
over-express	over-express	VB	0
the	the	DT	0
enzyme	enzyme	JJ	0
several	several	JJ	0
fold	fold	NN	0
as	as	IN	0
previously	previously	RB	0
reported	reported	VBD	0
[	[	-LRB-	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
Cytosolic	Cytosolic	NNP	0
PLA	PLA	NNP	0
2	2	CD	0
has	has	VBZ	0
been	been	VBN	0
shown	shown	VBN	0
to	to	TO	0
mediate	mediate	VB	0
Ca	Ca	NNP	0
2+-induced	2+-induced	NNP	0
AA	AA	NN	0
release	release	NN	0
in	in	IN	0
MDCK	MDCK	NNP	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
ATP	ATP	NNP	0
and	and	CC	0
IONO	IONO	NNP	0
in	in	IN	0
experiments	experiments	NNS	0
using	using	VBG	0
the	the	DT	0
group	group	NN	0
IV	IV	NNP	0
cPLA	cPLA	NNP	0
2	2	CD	0
α-specific	α-specific	JJ	0
inhibitor	inhibitor	JJ	0
pyrrolidine-1	pyrrolidine-1	NNP	0
[	[	-LRB-	0
27	27	CD	0
]	]	-RRB-	0
.	.	.	0
To	To	TO	0
measure	measure	VB	0
cPLA	cPLA	JJ	0
2	2	CD	0
mediated	mediated	JJ	0
AA	AA	NN	0
release	release	NN	0
,	,	,	0
EGFP-cPLA	EGFP-cPLA	JJ	0
2	2	CD	0
-transfected	-transfected	JJ	0
MDCK	MDCK	NN	0
cells	cells	NNS	0
labeled	labeled	VBN	0
with	with	IN	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
-AA	-AA	NNP	0
were	were	VBD	0
incubated	incubated	VBN	0
with	with	IN	0
0.3	0.3	CD	0
,	,	,	0
1	1	CD	0
or	or	CC	0
10	10	CD	0
μM	μM	JJ	0
U0126	U0126	NN	0
for	for	IN	0
15	15	CD	0
min	min	NNS	0
prior	prior	RB	0
to	to	TO	0
stimulation	stimulation	VB	0
with	with	IN	0
100	100	CD	0
μM	μM	JJ	0
ATP	ATP	NNP	0
,	,	,	0
1	1	CD	0
μM	μM	JJ	0
IONO	IONO	NNP	0
,	,	,	0
or	or	CC	0
10	10	CD	0
μM	μM	JJ	0
IONO	IONO	NNP	0
.	.	.	0
AA	AA	NN	0
release	release	NN	0
was	was	VBD	0
measured	measured	VBN	0
at	at	IN	0
3	3	CD	0
min	min	NN	0
because	because	IN	0
we	we	PRP	0
have	have	VBP	0
shown	shown	VBN	0
that	that	IN	0
ATP-	ATP-	JJ	0
and	and	CC	0
IONO-stimulated	IONO-stimulated	JJ	0
AA	AA	NN	0
release	release	NN	0
peaks	peaks	NNS	0
between	between	IN	0
3	3	CD	0
to	to	TO	0
5	5	CD	0
min	min	CD	0
post-stimulation	post-stimulation	NNS	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
Agonist-induced	Agonist-induced	JJ	B-NP
AA	AA	NN	I-NP
release	release	NN	I-NP
was	was	VBD	0
inhibited	inhibited	JJ	0
dose-dependently	dose-dependently	NN	B-NP
by	by	IN	0
U0126	U0126	NNP	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
)	)	-RRB-	0
with	with	IN	0
the	the	DT	0
highest	highest	JJS	0
U0126	U0126	CD	0
concentration	concentration	NN	B-NP
used	used	VBN	0
(	(	-LRB-	0
10	10	CD	0
μM	μM	NN	B-NP
)	)	-RRB-	0
reducing	reducing	VBG	B-NP
AA	AA	NN	I-NP
release	release	NN	I-NP
by	by	IN	0
72-80	72-80	CD	0
%	%	NN	0
with	with	IN	0
all	all	DT	0
agonist	agonist	NN	B-NP
(	(	-LRB-	0
Table	Table	NNP	0
I	I	NNP	0
)	)	-RRB-	0
.	.	.	0
This	This	DT	0
inhibition	inhibition	NN	0
was	was	VBD	0
independent	independent	JJ	0
of	of	IN	0
the	the	DT	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
total	total	JJ	I-NP
amount	amount	NN	I-NP
released	released	VBN	0
,	,	,	0
since	since	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
stimulated	stimulated	VBN	0
by	by	IN	0
10	10	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
was	was	VBD	0
3-fold	3-fold	CD	0
greater	greater	JJR	0
than	than	IN	0
release	release	NN	0
stimulated	stimulated	VBN	0
with	with	IN	0
1	1	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
or	or	CC	0
100	100	CD	0
μM	μM	JJ	B-NP
ATP	ATP	NNP	I-NP
,	,	,	0
but	but	CC	0
the	the	DT	0
percent	percent	NN	0
inhibition	inhibition	NN	0
by	by	IN	0
U0126	U0126	NNP	0
was	was	VBD	0
similar	similar	JJ	0
.	.	.	0
Treatment	Treatment	NN	0
of	of	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
with	with	IN	0
30	30	CD	0
μM	μM	JJ	0
PD098059	PD098059	NN	0
,	,	,	0
a	a	DT	0
less	less	RBR	0
potent	potent	JJ	0
inhibitor	inhibitor	NN	0
of	of	IN	0
MEK	MEK	NNP	B-NP
[	[	-LRB-	0
28	28	CD	0
29	29	CD	0
]	]	-RRB-	0
,	,	,	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
~50	~50	JJ	0
%	%	NN	0
reduction	reduction	NN	0
in	in	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
100	100	CD	0
μM	μM	JJ	B-NP
ATP	ATP	NNP	I-NP
,	,	,	0
1	1	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
,	,	,	0
and	and	CC	0
10	10	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
in	in	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
,	,	,	0
MEK1	MEK1	NNP	B-NP
inhibition	inhibition	VBD	I-NP
significantly	significantly	RB	0
reduces	reduces	VBZ	0
the	the	DT	0
ability	ability	NN	B-NP
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
to	to	TO	0
hydrolyze	hydrolyze	VB	0
arachidonic	arachidonic	NN	B-NP
acid	acid	JJ	I-NP
from	from	IN	0
membrane	membrane	JJ	B-NP
phospholipid	phospholipid	NN	I-NP
.	.	.	0
The	The	DT	0
effect	effect	NN	0
of	of	IN	0
MEK1	MEK1	CD	B-NP
inhibition	inhibition	NN	I-NP
on	on	IN	0
p42	p42	NNP	B-NP
activation	activation	NN	I-NP
/	/	NNP	0
p44	p44	NNP	B-NP
ERK	ERK	NNP	I-NP
measured	measured	VBD	0
by	by	IN	0
immunoblot	immunoblot	JJ	B-NP
analysis	analysis	NN	I-NP
using	using	VBG	0
phospho-specific	phospho-specific	JJ	B-NP
antibody	antibody	NN	I-NP
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
U0126	U0126	NNP	0
and	and	CC	0
stimulated	stimulated	VBN	0
as	as	IN	0
above	above	RB	0
was	was	VBD	0
determined	determined	VBN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
.	.	.	0
Work	Work	NN	0
in	in	IN	0
our	our	PRP$	0
laboratory	laboratory	NN	0
has	has	VBZ	0
shown	shown	VBN	0
that	that	IN	0
recognition	recognition	NN	0
of	of	IN	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
by	by	IN	0
anti-phospho-erk	anti-phospho-erk	NN	B-NP
antibody	antibody	NN	I-NP
correlates	correlates	VBN	0
with	with	IN	0
an	an	DT	0
increase	increase	NN	0
in	in	IN	0
ERK	ERK	NNP	B-NP
activity	activity	NN	I-NP
[	[	-LRB-	0
21	21	CD	0
30	30	CD	0
31	31	CD	0
]	]	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
the	the	DT	0
anti-phospho-erk	anti-phospho-erk	NN	B-NP
immunoblot	immunoblot	NN	I-NP
revealed	revealed	VBD	0
that	that	IN	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
were	were	VBD	0
constitutively	constitutively	VBN	0
activated	activated	VBN	0
in	in	IN	0
untreated	untreated	NN	0
,	,	,	0
quiesced	quiesced	JJ	B-NP
mdck	mdck	NN	I-NP
cell	cell	NN	I-NP
and	and	CC	0
activation	activation	NN	B-NP
was	was	VBD	0
not	not	RB	0
enhanced	enhanced	VBN	0
further	further	RBR	0
by	by	IN	0
ATP	ATP	NNP	B-NP
or	or	CC	0
IONO	IONO	NNP	B-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
,	,	,	0
left	left	VBN	0
panel	panel	NN	0
)	)	-RRB-	0
.	.	.	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
was	was	VBD	0
diminished	diminished	VBN	0
by	by	IN	0
increasing	increasing	VBG	B-NP
concentration	concentration	NN	I-NP
of	of	IN	0
U0126	U0126	NNP	0
and	and	CC	0
was	was	VBD	0
quantitatively	quantitatively	JJ	0
inhibited	inhibited	NN	0
after	after	IN	0
15	15	CD	0
min	min	JJ	B-NP
incubation	incubation	NN	I-NP
in	in	IN	0
10	10	CD	0
μM	μM	JJ	0
U0126	U0126	NN	0
.	.	.	0
U0126	U0126	NNP	0
decreased	decreased	VBD	B-NP
ERK	ERK	NNP	I-NP
activation	activation	VBZ	I-NP
following	following	VBG	0
ATP	ATP	NNP	B-NP
or	or	CC	0
IONO	IONO	NNP	B-NP
stimulation	stimulation	NN	I-NP
in	in	IN	0
the	the	DT	0
same	same	JJ	0
fashion	fashion	NN	0
as	as	IN	0
in	in	IN	0
unstimulated	unstimulated	JJ	B-NP
cell	cell	NN	I-NP
.	.	.	0
Consequently	Consequently	RB	0
,	,	,	0
there	there	EX	0
was	was	VBD	0
a	a	DT	0
direct	direct	JJ	0
correlation	correlation	NN	0
between	between	IN	0
the	the	DT	0
reduction	reduction	NN	0
of	of	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1A	1A	NNP	0
)	)	-RRB-	0
and	and	CC	0
inhibition	inhibition	NN	0
of	of	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1B	1B	NNP	0
)	)	-RRB-	0
in	in	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
treated	treated	VBN	0
with	with	IN	0
U0126	U0126	CD	0
.	.	.	0
Because	Because	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
is	is	VBZ	0
a	a	DT	0
target	target	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	FW	0
/	/	FW	0
ERK	ERK	FW	0
signaling	signaling	FW	0
cascade	cascade	FW	0
,	,	,	0
we	we	PRP	0
assayed	assayed	VBD	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
MEK1	MEK1	CD	0
inhibition	inhibition	NN	0
by	by	IN	0
U0126	U0126	CD	0
on	on	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
phosphorylation	phosphorylation	NN	0
by	by	IN	0
analyzing	analyzing	VBG	0
gel	gel	JJ	0
shift	shift	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
Phosphorylation	Phosphorylation	NNP	0
of	of	IN	0
Ser	Ser	NNP	0
505results	505results	NNP	0
in	in	IN	0
a	a	DT	0
retardation	retardation	NN	0
of	of	IN	0
its	its	PRP$	0
electrophoretic	electrophoretic	JJ	0
mobility	mobility	NNS	0
(	(	-LRB-	0
gel	gel	JJ	0
shift	shift	NN	0
)	)	-RRB-	0
[	[	-LRB-	0
13	13	CD	0
16	16	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
unstimulated	unstimulated	JJ	0
cells	cells	NNS	0
,	,	,	0
EGFP-tagged	EGFP-tagged	JJ	0
and	and	CC	0
endogenous	endogenous	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
were	were	VBD	0
nearly	nearly	RB	0
completely	completely	RB	0
gel	gel	JJ	0
shifted	shifted	NN	0
,	,	,	0
indicating	indicating	VBG	0
that	that	DT	0
most	most	RBS	0
cPLA	cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
phosphorylated	phosphorylated	VBN	0
on	on	IN	0
Ser	Ser	NNP	0
505	505	CD	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
1C	1C	NNP	0
)	)	-RRB-	0
,	,	,	0
which	which	WDT	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
the	the	DT	0
observation	observation	NN	0
that	that	IN	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
are	are	VBP	0
constitutively	constitutively	JJ	B-NP
activated	activated	NN	I-NP
.	.	.	0
Incubation	Incubation	NNP	0
with	with	IN	0
U0126	U0126	NNP	0
resulted	resulted	VBD	0
in	in	IN	0
a	a	DT	0
partial	partial	JJ	0
reversal	reversal	NN	0
of	of	IN	0
the	the	DT	0
gel	gel	JJ	B-NP
shift	shift	NN	I-NP
although	although	IN	0
,	,	,	0
at	at	IN	0
10	10	CD	0
μM	μM	JJ	0
U0126	U0126	NN	0
,	,	,	0
approximately	approximately	RB	0
half	half	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
remained	remained	VBD	0
phosphorylated	phosphorylated	VBN	0
on	on	IN	0
Ser	Ser	NNP	0
505	505	CD	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
unlike	unlike	IN	0
the	the	DT	0
quantitative	quantitative	JJ	B-NP
effect	effect	NN	I-NP
of	of	IN	0
U0126	U0126	CD	0
on	on	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
,	,	,	0
inhibition	inhibition	VBG	0
of	of	IN	0
MEK1	MEK1	CD	B-NP
with	with	IN	0
U0126	U0126	NNP	0
only	only	RB	0
partially	partially	RB	0
reversed	reversed	VBD	0
the	the	DT	0
gel	gel	JJ	B-NP
shift	shift	NN	I-NP
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
The	The	DT	0
reversal	reversal	NN	0
of	of	IN	0
the	the	DT	0
gel	gel	JJ	B-NP
shift	shift	NN	I-NP
was	was	VBD	0
similar	similar	JJ	0
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
ATP	ATP	NNP	B-NP
and	and	CC	0
1	1	CD	0
and	and	CC	0
10	10	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
.	.	.	0
Due	Due	JJ	0
to	to	TO	0
the	the	DT	0
increased	increased	JJ	0
molecular	molecular	JJ	0
weight	weight	NN	0
of	of	IN	0
the	the	DT	0
EGFP-tagged	EGFP-tagged	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
,	,	,	0
the	the	DT	0
two	two	CD	0
forms	forms	NNS	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
did	did	VBD	0
not	not	RB	0
separate	separate	JJ	0
as	as	IN	0
well	well	RB	0
,	,	,	0
making	making	VBG	0
the	the	DT	0
gel	gel	JJ	0
shift	shift	NN	0
more	more	RBR	0
difficult	difficult	JJ	0
to	to	TO	0
visualize	visualize	VB	0
,	,	,	0
but	but	CC	0
generally	generally	RB	0
mirrored	mirrored	VBD	0
the	the	DT	0
gel	gel	JJ	0
shift	shift	NN	0
characteristics	characteristics	NNS	0
of	of	IN	0
the	the	DT	0
endogenous	endogenous	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
suggest	suggest	VBP	0
that	that	RB	0
,	,	,	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
MEK1	MEK1	CD	0
inhibition	inhibition	NN	0
,	,	,	0
there	there	EX	0
is	is	VBZ	0
a	a	DT	0
quantitative	quantitative	JJ	0
,	,	,	0
dose-dependent	dose-dependent	JJ	0
decrease	decrease	NN	0
in	in	IN	0
AA	AA	NN	0
release	release	NN	0
that	that	WDT	0
correlates	correlates	VBP	0
well	well	RB	0
with	with	IN	0
the	the	DT	0
loss	loss	NN	0
of	of	IN	0
ERK	ERK	NNP	0
activation	activation	NN	0
,	,	,	0
but	but	CC	0
not	not	RB	0
with	with	IN	0
the	the	DT	0
extent	extent	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
.	.	.	0
To	To	TO	0
further	further	RB	0
investigate	investigate	VB	0
whether	whether	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
played	played	VBD	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
regulating	regulating	VBG	B-NP
AA	AA	NN	I-NP
release	release	NN	I-NP
independent	independent	JJ	0
of	of	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
,	,	,	0
we	we	PRP	0
treated	treated	VBD	0
cells	cells	NNS	0
with	with	IN	0
anisomycin	anisomycin	NN	B-NP
,	,	,	0
which	which	WDT	0
activates	activates	VBZ	0
the	the	DT	0
map	map	NN	B-NP
kinase	kinase	NN	I-NP
homolog	homolog	VBD	0
p38	p38	CD	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
the	the	DT	0
MEK1	MEK1	NN	B-NP
/	/	FW	0
ERK	ERK	NN	B-NP
pathway	pathway	NN	I-NP
[	[	-LRB-	0
32	32	CD	0
]	]	-RRB-	0
.	.	.	0
p38	p38	CD	B-NP
activation	activation	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
anisomycin	anisomycin	VB	0
treatment	treatment	NN	0
was	was	VBD	0
analyzed	analyzed	VBN	0
by	by	IN	0
immunoblotting	immunoblotting	NN	B-NP
using	using	VBG	0
an	an	DT	0
anti-phospho-p38	anti-phospho-p38	JJ	B-NP
antibody	antibody	NN	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2A	2A	NNP	0
)	)	-RRB-	0
.	.	.	0
The	The	DT	0
immunoblots	immunoblots	JJ	0
demonstrate	demonstrate	NN	0
that	that	IN	0
30	30	CD	0
min	min	JJ	B-NP
treatment	treatment	NN	I-NP
in	in	IN	0
25	25	CD	0
ng	ng	CD	B-NP
/	/	CD	I-NP
ml	ml	NN	I-NP
anisomycin	anisomycin	VBP	0
resulted	resulted	VBN	0
in	in	IN	0
p38	p38	CD	B-NP
phosphorylation	phosphorylation	NN	I-NP
in	in	IN	0
unstimulated	unstimulated	JJ	B-NP
mdck	mdck	NN	I-NP
cell	cell	NN	I-NP
and	and	CC	0
in	in	IN	0
cells	cells	NNS	0
treated	treated	VBN	0
with	with	IN	0
ATP	ATP	NNP	B-NP
or	or	CC	0
IONO	IONO	NNP	B-NP
.	.	.	0
ATP	ATP	NNP	B-NP
and	and	CC	0
ionomycin	ionomycin	JJ	B-NP
treatment	treatment	NN	I-NP
in	in	IN	0
the	the	DT	0
anisomycin	anisomycin	JJ	B-NP
only	only	JJ	I-NP
absence	absence	NN	I-NP
weakly	weakly	NN	0
increased	increased	VBD	B-NP
p38	p38	CD	I-NP
phosphorylation	phosphorylation	NN	I-NP
.	.	.	0
As	As	RB	0
expected	expected	VBN	0
,	,	,	0
the	the	DT	0
MEK	MEK	NNP	B-NP
inhibitor	inhibitor	VBD	I-NP
U0126	U0126	NNP	0
did	did	VBD	0
not	not	RB	0
significantly	significantly	RB	0
affect	affect	VB	0
anisomycin-stimulated	anisomycin-stimulated	JJ	B-NP
p38	p38	CD	I-NP
phosphorylation	phosphorylation	NN	I-NP
.	.	.	0
In	In	IN	0
control	control	NN	B-NP
experiment	experiment	NN	I-NP
,	,	,	0
anisomycin	anisomycin	JJ	B-NP
treatment	treatment	NN	I-NP
did	did	VBD	0
not	not	RB	0
induce	induce	VB	0
ERK	ERK	JJ	B-NP
activation	activation	NN	I-NP
nor	nor	CC	0
interfere	interfere	VB	0
with	with	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
by	by	IN	0
10	10	CD	0
μM	μM	JJ	0
U0126	U0126	CD	0
treatment	treatment	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2B	2B	NNP	0
)	)	-RRB-	0
.	.	.	0
We	We	PRP	0
have	have	VBP	0
previously	previously	RB	0
reported	reported	VBN	0
that	that	IN	0
p38	p38	NNP	B-NP
is	is	VBZ	0
also	also	RB	0
selectively	selectively	RB	0
activated	activated	VBN	0
in	in	IN	0
anisomycin-treated	anisomycin-treated	JJ	B-NP
macrophage	macrophage	NN	I-NP
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
Importantly	Importantly	RB	0
,	,	,	0
pretreatment	pretreatment	VBG	0
of	of	IN	0
cells	cells	NNS	0
for	for	IN	0
30	30	CD	0
min	min	NN	B-NP
with	with	IN	0
anisomycin	anisomycin	NN	B-NP
resulted	resulted	VBD	0
in	in	IN	0
maintenance	maintenance	NN	0
of	of	IN	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
gel	gel	JJ	B-NP
shift	shift	NN	I-NP
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
of	of	IN	0
U0126	U0126	CD	0
in	in	IN	0
unstimulated	unstimulated	JJ	B-NP
cell	cell	NN	I-NP
and	and	CC	0
in	in	IN	0
cells	cells	NNS	0
stimulated	stimulated	VBN	0
with	with	IN	0
ATP	ATP	NNP	B-NP
and	and	CC	0
1	1	CD	0
and	and	CC	0
10	10	CD	0
μM	μM	JJ	B-NP
IONO	IONO	NNP	I-NP
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2C	2C	NNP	0
)	)	-RRB-	0
.	.	.	0
aa	aa	NN	B-NP
release	release	NN	I-NP
assay	assay	NN	I-NP
show	show	VBP	0
that	that	RB	0
,	,	,	0
in	in	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
treated	treated	VBN	0
with	with	IN	0
anisomycin	anisomycin	NN	B-NP
,	,	,	0
U0126	U0126	NNP	0
resulted	resulted	VBD	0
in	in	IN	0
an	an	DT	0
AA	AA	NN	B-NP
release	release	NN	I-NP
reduction	reduction	NN	I-NP
of	of	IN	0
~67-76	~67-76	CD	0
%	%	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
2D	2D	NNP	0
)	)	-RRB-	0
similar	similar	JJ	0
to	to	TO	0
the	the	DT	0
inhibition	inhibition	NN	0
observed	observed	VBD	0
without	without	IN	0
anisomycin	anisomycin	NN	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
that	that	DT	0
activation	activation	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
pathway	pathway	NN	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
AA	AA	NN	0
release	release	NN	0
even	even	RB	0
under	under	IN	0
conditions	conditions	NNS	0
where	where	WRB	0
cPLA	cPLA	JJ	0
2	2	CD	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
is	is	VBZ	0
maintained	maintained	VBN	0
,	,	,	0
suggesting	suggesting	VBG	0
an	an	DT	0
alternative	alternative	JJ	0
role	role	NN	0
for	for	IN	0
the	the	DT	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
pathway	pathway	NN	0
in	in	IN	0
regulating	regulating	VBG	0
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
iincrease	iincrease	NN	0
is	is	VBZ	0
independent	independent	JJ	0
of	of	IN	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
pathway	pathway	VBD	0
One	One	CD	0
explanation	explanation	NN	0
for	for	IN	0
the	the	DT	0
decrease	decrease	NN	0
in	in	IN	0
AA	AA	NN	0
is	is	VBZ	0
that	that	IN	0
U0126	U0126	CD	0
inhibits	inhibits	NNS	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization	mobilization	FW	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
ATP	ATP	NNP	0
or	or	CC	0
IONO	IONO	NNP	0
,	,	,	0
thereby	thereby	RB	0
preventing	preventing	VBG	0
translocation	translocation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
.	.	.	0
In	In	IN	0
chick	chick	JJ	0
ventricular	ventricular	JJ	0
myocytes	myocytes	NN	0
,	,	,	0
inhibition	inhibition	VBG	0
of	of	IN	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
by	by	IN	0
PD98059	PD98059	CD	0
inhibits	inhibits	CD	0
zinterol-mediated	zinterol-mediated	JJ	0
AA	AA	NN	0
release	release	NN	0
,	,	,	0
but	but	CC	0
also	also	RB	0
inhibits	inhibits	JJ	0
zinterol-induced	zinterol-induced	JJ	0
stimulation	stimulation	NN	0
of	of	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
cycling	cycling	FW	0
in	in	FW	0
electrically	electrically	FW	0
stimulated	stimulated	FW	0
cells	cells	FW	0
[	[	-LRB-	0
33	33	CD	0
]	]	-RRB-	0
.	.	.	0
In	In	IN	0
MDCK	MDCK	NNP	0
cells	cells	NNS	0
,	,	,	0
extracellular	extracellular	VBG	0
ATP	ATP	NNP	0
acts	acts	VBZ	0
via	via	IN	0
P	P	NN	0
2Y2	2Y2	CD	0
receptors	receptors	NNS	0
to	to	TO	0
elicit	elicit	VB	0
an	an	DT	0
IP	IP	NNP	0
3	3	CD	0
-mediated	-mediated	NNS	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
[	[	-LRB-	0
34	34	CD	0
]	]	-RRB-	0
and	and	CC	0
IONO	IONO	NNP	0
acts	acts	VBZ	0
to	to	TO	0
increase	increase	VB	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	NN	0
by	by	IN	0
permeabilizing	permeabilizing	JJ	0
cell	cell	NN	0
membranes	membranes	NN	0
to	to	TO	0
Ca	Ca	NNP	0
2+	2+	NNP	0
.	.	.	0
To	To	TO	0
determine	determine	VB	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
U0126	U0126	CD	0
on	on	IN	0
intracellular	intracellular	JJ	0
Ca	Ca	JJ	0
2+mobilization	2+mobilization	NN	0
by	by	IN	0
100	100	CD	0
μM	μM	JJ	0
ATP	ATP	NNP	0
or	or	CC	0
10	10	CD	0
μM	μM	JJ	0
IONO	IONO	NNP	0
,	,	,	0
we	we	PRP	0
utilized	utilized	VBP	0
single-cell	single-cell	JJ	0
fluorescence	fluorescence	JJ	0
microscopy	microscopy	NN	0
on	on	IN	0
cells	cells	NNS	0
loaded	loaded	VBN	0
with	with	IN	0
the	the	DT	0
calcium	calcium	JJ	0
indicator	indicator	NN	0
Fura2	Fura2	NN	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
the	the	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
in	in	IN	0
individual	individual	JJ	0
cells	cells	NNS	0
reveals	reveals	VBZ	0
the	the	DT	0
heterogeneity	heterogeneity	NN	0
in	in	IN	0
the	the	DT	0
response	response	NN	0
to	to	TO	0
ATP	ATP	NNP	0
,	,	,	0
although	although	IN	0
most	most	JJS	0
cells	cells	NNS	0
exhibited	exhibited	VBP	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
spikes	spikes	FW	0
of	of	IN	0
similar	similar	JJ	0
magnitude	magnitude	NN	0
and	and	CC	0
duration	duration	NN	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3Aand	3Aand	NNP	0
3B	3B	NNP	0
,	,	,	0
thin	thin	JJ	0
lines	lines	NNS	0
)	)	-RRB-	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
the	the	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
in	in	IN	0
several	several	JJ	0
cells	cells	NNS	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
3Aand	3Aand	NNP	0
3B	3B	NNP	0
,	,	,	0
thick	thick	JJ	0
line	line	NN	0
)	)	-RRB-	0
revealed	revealed	VBD	0
that	that	IN	0
although	although	IN	0
the	the	DT	0
duration	duration	NN	0
of	of	IN	0
the	the	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
elicited	elicited	NN	0
by	by	IN	0
ATP	ATP	NNP	0
in	in	IN	0
control	control	NN	0
cells	cells	NNS	0
was	was	VBD	0
the	the	DT	0
same	same	JJ	0
as	as	IN	0
in	in	IN	0
the	the	DT	0
U0126-treated	U0126-treated	CD	0
cells	cells	NNS	0
,	,	,	0
approximately	approximately	RB	0
3-4	3-4	CD	0
min	min	NN	0
,	,	,	0
the	the	DT	0
amplitude	amplitude	NN	0
of	of	IN	0
the	the	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
was	was	VBD	0
slightly	slightly	RB	0
higher	higher	JJR	0
(	(	-LRB-	0
~20	~20	NNP	0
%	%	NN	0
)	)	-RRB-	0
in	in	IN	0
the	the	DT	0
U0126-treated	U0126-treated	CD	0
cells	cells	NNS	0
.	.	.	0
IONO	IONO	NNP	0
elicited	elicited	VBD	0
a	a	DT	0
sustained	sustained	JJ	0
,	,	,	0
supraphysiological	supraphysiological	NNS	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
in	in	IN	0
cells	cells	NNS	0
that	that	WDT	0
was	was	VBD	0
also	also	RB	0
slightly	slightly	RB	0
enhanced	enhanced	VBN	0
by	by	IN	0
U0126	U0126	NNP	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
3Cand	3Cand	CD	0
3D	3D	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
experiments	experiments	NNS	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
U0126	U0126	NNP	0
does	does	VBZ	0
not	not	RB	0
decrease	decrease	VB	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization	mobilization	FW	0
,	,	,	0
and	and	CC	0
the	the	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
AA	AA	NN	0
release	release	NN	0
by	by	IN	0
U0126	U0126	CD	0
cannot	cannot	NNS	0
be	be	VB	0
ascribed	ascribed	VBN	0
to	to	TO	0
a	a	DT	0
failure	failure	NN	0
in	in	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization.	mobilization.	FW	0
cPLA	cPLA	FW	0
2translocation	2translocation	FW	0
is	is	VBZ	0
independent	independent	JJ	0
of	of	IN	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
pathway	pathway	VBD	0
The	The	DT	0
effect	effect	NN	0
of	of	IN	0
inhibition	inhibition	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
pathway	pathway	NN	0
by	by	IN	0
U0126	U0126	CD	0
on	on	IN	0
translocation	translocation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
investigated	investigated	VBN	0
.	.	.	0
Although	Although	IN	0
there	there	EX	0
is	is	VBZ	0
no	no	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
release	release	NN	0
by	by	IN	0
U0126	U0126	NNP	0
and	and	CC	0
little	little	JJ	0
effect	effect	NN	0
on	on	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
MEK1	MEK1	CD	0
inhibition	inhibition	NN	0
by	by	IN	0
U0126	U0126	NNP	0
prevents	prevents	VBZ	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	NN	0
by	by	IN	0
another	another	DT	0
mechanism	mechanism	NN	0
.	.	.	0
To	To	TO	0
investigate	investigate	VB	0
this	this	DT	0
possibility	possibility	NN	0
,	,	,	0
cells	cells	NNS	0
were	were	VBD	0
transfected	transfected	VBN	0
with	with	IN	0
a	a	DT	0
wild-type	wild-type	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
fused	fused	NN	0
to	to	TO	0
EYFP	EYFP	NNP	0
(	(	-LRB-	0
EYFP-cPLA	EYFP-cPLA	NNP	0
2	2	CD	0
)	)	-RRB-	0
and	and	CC	0
the	the	DT	0
distribution	distribution	NN	0
of	of	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
imaged	imaged	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
transients	transients	FW	0
elicited	elicited	FW	0
by	by	IN	0
ATP	ATP	NNP	0
and	and	CC	0
sustained	sustained	VBD	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
elevations	elevations	FW	0
elicited	elicited	FW	0
by	by	IN	0
IONO	IONO	NNP	0
,	,	,	0
in	in	IN	0
the	the	DT	0
presence	presence	NN	0
and	and	CC	0
absence	absence	NN	0
of	of	IN	0
U0126	U0126	CD	0
.	.	.	0
Following	Following	VBG	0
stimulation	stimulation	NN	0
with	with	IN	0
100	100	CD	0
μM	μM	JJ	0
ATP	ATP	NNP	0
,	,	,	0
there	there	EX	0
was	was	VBD	0
a	a	DT	0
rapid	rapid	JJ	0
translocation	translocation	NN	0
of	of	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
to	to	TO	0
Golgi	Golgi	NNP	0
that	that	WDT	0
was	was	VBD	0
unaffected	unaffected	VBN	0
by	by	IN	0
U0126	U0126	NNP	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4A	4A	NNP	0
,	,	,	0
4B	4B	CD	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
response	response	NN	0
to	to	TO	0
physiological	physiological	VB	0
agonists	agonists	VBN	0
that	that	IN	0
elicit	elicit	JJ	0
transient	transient	NNS	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
changes	changes	NNS	0
,	,	,	0
only	only	RB	0
a	a	DT	0
small	small	JJ	0
fraction	fraction	NN	0
of	of	IN	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocates	translocates	NNS	0
.	.	.	0
This	This	DT	0
observation	observation	NN	0
is	is	VBZ	0
consistent	consistent	JJ	0
with	with	IN	0
our	our	PRP$	0
previous	previous	JJ	0
results	results	NNS	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
and	and	CC	0
has	has	VBZ	0
been	been	VBN	0
demonstrated	demonstrated	VBN	0
by	by	IN	0
Hirabayashi	Hirabayashi	NNP	0
et	et	FW	0
al.	al.	FW	0
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
Most	Most	JJS	0
studies	studies	NNS	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	NNS	0
have	have	VBP	0
utilized	utilized	JJ	0
ionophore	ionophore	NN	0
,	,	,	0
which	which	WDT	0
elicits	elicits	VBZ	0
a	a	DT	0
large	large	JJ	0
,	,	,	0
supraphysiological	supraphysiological	VBD	0
sustained	sustained	VBN	0
increase	increase	NN	0
in	in	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
[	[	-LRB-	0
14	14	CD	0
15	15	CD	0
25	25	CD	0
35	35	CD	0
36	36	CD	0
37	37	CD	0
38	38	CD	0
]	]	-RRB-	0
,	,	,	0
or	or	CC	0
agonists	agonists	NNS	0
that	that	WDT	0
produce	produce	VBP	0
a	a	DT	0
sustained	sustained	JJ	0
[	[	-LRB-	0
Ca	Ca	NNP	0
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
[	[	-LRB-	0
35	35	CD	0
]	]	-RRB-	0
.	.	.	0
Under	Under	IN	0
these	these	DT	0
conditions	conditions	NNS	0
,	,	,	0
a	a	DT	0
large	large	JJ	0
proportion	proportion	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
binds	binds	NN	0
to	to	TO	0
membrane	membrane	VB	0
.	.	.	0
These	These	DT	0
studies	studies	NNS	0
show	show	VBP	0
extensive	extensive	JJ	0
translocation	translocation	NN	0
to	to	TO	0
the	the	DT	0
endoplasmic	endoplasmic	JJ	B-NP
reticulum	reticulum	NN	I-NP
(	(	-LRB-	0
endoplasmic	endoplasmic	NN	B-NP
reticulum	reticulum	NN	I-NP
)	)	-RRB-	0
,	,	,	0
nuclear	nuclear	JJ	0
envelope	envelope	NN	0
and	and	CC	0
Golgi	Golgi	NNP	0
[	[	-LRB-	0
14	14	CD	0
15	15	CD	0
35	35	CD	0
36	36	CD	0
38	38	CD	0
]	]	-RRB-	0
.	.	.	0
We	We	PRP	0
found	found	VBD	0
that	that	IN	0
U0126	U0126	NNP	0
also	also	RB	0
failed	failed	VBN	0
to	to	TO	0
alter	alter	VB	0
extensive	extensive	JJ	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
translocation	translocation	NN	0
to	to	TO	0
Golgi	Golgi	NNP	0
and	and	CC	0
ER	ER	NNP	0
in	in	IN	0
response	response	NN	0
10	10	CD	0
μM	μM	JJ	0
IONO	IONO	NNP	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
4C	4C	NNP	0
,	,	,	0
4D	4D	CD	0
)	)	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
that	that	IN	0
MEK	MEK	NNP	0
inhibition	inhibition	NN	0
has	has	VBZ	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	NNS	0
.	.	.	0
phosphorylation	phosphorylation	JJ	B-NP
site	site	NN	I-NP
translocation	translocation	NN	I-NP
mutants	mutants	VBD	0
S505A	S505A	CD	0
or	or	CC	0
S727A	S727A	NNP	0
is	is	VBZ	0
similar	similar	JJ	0
as	as	IN	0
wild-type	wild-type	JJ	B-NP
cPLA	cPLA	JJ	0
2	2	CD	0
Phosphorylation	Phosphorylation	NN	B-NP
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
on	on	IN	0
Ser	Ser	NNP	0
505has	505has	VBZ	0
been	been	VBN	0
hypothesized	hypothesized	VBN	0
to	to	TO	0
play	play	VB	0
a	a	DT	0
role	role	NN	0
in	in	IN	0
Ca	Ca	NNP	B-NP
2+-mediated	2+-mediated	NNP	0
translocation	translocation	NN	B-NP
since	since	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
-mediated	-mediated	JJ	0
AA	AA	NN	0
release	release	NN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
low-dose	low-dose	JJ	B-NP
,	,	,	0
but	but	CC	0
not	not	RB	0
high-dose	high-dose	JJ	B-NP
,	,	,	0
ionophora	ionophora	NN	B-NP
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
.	.	.	0
Translocation	Translocation	NNP	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
in	in	IN	0
CHO	CHO	NNP	0
cells	cells	NNS	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
ionophore	ionophore	VB	0
stimulation	stimulation	NNS	0
[	[	-LRB-	0
25	25	CD	0
]	]	-RRB-	0
,	,	,	0
but	but	CC	0
the	the	DT	0
effect	effect	NN	0
of	of	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
on	on	IN	0
the	the	DT	0
kinetics	kinetics	NN	0
of	of	IN	0
translocation	translocation	NN	0
,	,	,	0
targeting	targeting	VBG	0
,	,	,	0
and	and	CC	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
a	a	DT	0
physiological	physiological	JJ	0
agonist	agonist	NN	0
was	was	VBD	0
not	not	RB	0
investigated	investigated	VBN	0
.	.	.	0
MDCK	MDCK	NNP	0
cells	cells	NNS	0
were	were	VBD	0
co-transfected	co-transfected	JJ	0
with	with	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
and	and	CC	0
a	a	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
with	with	IN	0
a	a	DT	0
S505A	S505A	JJ	0
mutation	mutation	NN	0
fused	fused	NN	0
to	to	TO	0
ECFP	ECFP	NNP	0
(	(	-LRB-	0
ECFP-cPLA	ECFP-cPLA	NNP	0
2	2	CD	0
S505A	S505A	CD	0
)	)	-RRB-	0
.	.	.	0
Using	Using	VBG	0
dual	dual	JJ	0
EYFP	EYFP	NNP	0
/	/	NNP	0
ECFP	ECFP	NNP	0
imaging	imaging	NN	0
,	,	,	0
we	we	PRP	0
were	were	VBD	0
able	able	JJ	0
to	to	TO	0
directly	directly	RB	0
compare	compare	VB	0
translocation	translocation	VBN	0
of	of	IN	0
both	both	DT	0
constructs	constructs	NN	0
in	in	IN	0
the	the	DT	0
same	same	JJ	0
cell	cell	NN	0
.	.	.	0
The	The	DT	0
resting	resting	JJ	0
distribution	distribution	NN	0
of	of	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
similar	similar	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
ECFP-cPLA	ECFP-cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
and	and	CC	0
,	,	,	0
in	in	IN	0
response	response	NN	0
to	to	TO	0
ATP	ATP	NNP	0
followed	followed	VBD	0
by	by	IN	0
IONO	IONO	NNP	0
,	,	,	0
the	the	DT	0
pattern	pattern	NN	0
of	of	IN	0
translocation	translocation	NN	0
of	of	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
similar	similar	JJ	0
to	to	TO	0
ECFP-cPLA	ECFP-cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5panels	5panels	NNP	0
A	A	NNP	0
and	and	CC	0
B	B	NNP	0
,	,	,	0
D	D	NNP	0
)	)	-RRB-	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
fluorescence	fluorescence	NN	0
at	at	IN	0
the	the	DT	0
Golgi	Golgi	NNP	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
time	time	NN	0
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
rates	rates	NNS	0
of	of	IN	0
translocation	translocation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
elicited	elicited	NN	0
by	by	IN	0
ATP	ATP	NNP	0
followed	followed	VBD	0
by	by	IN	0
IONO	IONO	NNP	0
are	are	VBP	0
very	very	RB	0
similar	similar	JJ	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
5C	5C	NNP	0
)	)	-RRB-	0
.	.	.	0
As	As	RB	0
previously	previously	RB	0
reported	reported	VBD	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
,	,	,	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
mutation	mutation	NN	0
has	has	VBZ	0
a	a	DT	0
similar	similar	JJ	0
phenotype	phenotype	NN	0
on	on	IN	0
AA	AA	NN	0
release	release	NN	0
as	as	IN	0
the	the	DT	0
S505A	S505A	JJ	0
mutation	mutation	NN	0
and	and	CC	0
Ser	Ser	NNP	0
727was	727was	NNP	0
found	found	VBD	0
to	to	TO	0
be	be	VB	0
phosphorylated	phosphorylated	VBN	0
in	in	IN	0
tandem	tandem	NN	0
with	with	IN	0
Ser	Ser	NNP	0
505	505	CD	0
.	.	.	0
Imaging	Imaging	JJ	0
experiments	experiments	NNS	0
were	were	VBD	0
performed	performed	VBN	0
using	using	VBG	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
and	and	CC	0
ECFP-cPLA	ECFP-cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
and	and	CC	0
we	we	PRP	0
found	found	VBD	0
that	that	IN	0
the	the	DT	0
distribution	distribution	NN	0
of	of	IN	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
identical	identical	JJ	0
to	to	TO	0
that	that	DT	0
of	of	IN	0
ECFP-cPLA	ECFP-cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
before	before	IN	0
and	and	CC	0
after	after	IN	0
stimulation	stimulation	NN	0
with	with	IN	0
10	10	CD	0
μM	μM	JJ	0
IONO	IONO	NNP	0
(	(	-LRB-	0
Fig.	Fig.	CD	0
7	7	CD	0
panels	panels	NNS	0
A	A	DT	0
and	and	CC	0
B	B	NNP	0
,	,	,	0
D	D	NNP	0
)	)	-RRB-	0
.	.	.	0
Analysis	Analysis	NN	0
of	of	IN	0
the	the	DT	0
increase	increase	NN	0
in	in	IN	0
fluorescence	fluorescence	NN	0
at	at	IN	0
the	the	DT	0
Golgi	Golgi	NNP	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
time	time	NN	0
demonstrates	demonstrates	VBZ	0
that	that	IN	0
the	the	DT	0
rates	rates	NNS	0
of	of	IN	0
translocation	translocation	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
the	the	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
elicited	elicited	NN	0
by	by	IN	0
IONO	IONO	NNP	0
are	are	VBP	0
very	very	RB	0
similar	similar	JJ	0
(	(	-LRB-	0
Fig.	Fig.	NNP	0
6C	6C	NNP	0
)	)	-RRB-	0
.	.	.	0
Discussion	Discussion	NN	0
The	The	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
regulates	regulates	VBZ	0
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
ERKs	ERKs	JJ	B-NP
phosphorylate	phosphorylate	JJ	I-NP
cPLA	cPLA	JJ	I-NP
2	2	CD	0
on	on	IN	0
Ser	Ser	NNP	0
505	505	CD	0
.	.	.	0
The	The	DT	0
results	results	NNS	0
of	of	IN	0
this	this	DT	0
study	study	NN	0
demonstrate	demonstrate	NN	0
that	that	IN	0
this	this	DT	0
pathway	pathway	NN	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
-mediated	-mediated	JJ	0
AA	AA	NN	0
release	release	NN	0
independent	independent	JJ	0
of	of	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
and	and	CC	0
extend	extend	VB	0
our	our	PRP$	0
previous	previous	JJ	0
work	work	NN	0
in	in	IN	0
macrophage	macrophage	NN	B-NP
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
by	by	IN	0
demonstrating	demonstrating	VBG	0
that	that	IN	0
this	this	DT	0
alternative	alternative	JJ	0
role	role	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
is	is	VBZ	0
not	not	RB	0
involved	involved	VBN	0
in	in	IN	0
regulating	regulating	VBG	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
change	change	NN	0
or	or	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	CD	B-NP
kinetics	kinetics	NN	I-NP
or	or	CC	0
targeting	targeting	VBG	0
,	,	,	0
but	but	CC	0
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
optimal	optimal	JJ	B-NP
hydrolytic	hydrolytic	JJ	I-NP
activity	activity	NN	I-NP
and	and	CC	0
AA	AA	NN	B-NP
release	release	NN	I-NP
.	.	.	0
The	The	DT	0
results	results	NNS	0
shown	shown	VBN	0
here	here	RB	0
demonstrate	demonstrate	VB	0
that	that	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
MEK	MEK	NNP	B-NP
with	with	IN	0
U0126	U0126	CD	0
quantitatively	quantitatively	NNS	0
inhibits	inhibits	VBP	0
both	both	DT	0
ERK	ERK	NNP	B-NP
phosphorylation	phosphorylation	NN	I-NP
and	and	CC	0
AA	AA	NN	B-NP
release	release	NN	I-NP
in	in	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization	mobilization	NN	B-NP
.	.	.	0
The	The	DT	0
MEK	MEK	NNP	B-NP
inhibitor	inhibitor	VBD	I-NP
PD098059	PD098059	CD	0
,	,	,	0
a	a	DT	0
less	less	RBR	0
potent	potent	JJ	0
inhibitor	inhibitor	NNS	0
[	[	-LRB-	0
28	28	CD	0
29	29	CD	0
]	]	-RRB-	0
,	,	,	0
also	also	RB	0
inhibited	inhibited	VBD	0
ATP-	ATP-	JJ	0
and	and	CC	0
IONO-induced	IONO-induced	JJ	B-NP
AA	AA	NN	I-NP
release	release	NN	I-NP
(	(	-LRB-	0
data	data	NNS	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
was	was	VBD	0
found	found	VBN	0
to	to	TO	0
be	be	VB	0
constitutively	constitutively	JJ	0
phosphorylated	phosphorylated	NN	0
in	in	IN	0
our	our	PRP$	0
study	study	NN	0
using	using	VBG	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
from	from	IN	0
ATCC	ATCC	NNP	B-NP
,	,	,	0
in	in	IN	0
contrast	contrast	NN	0
to	to	TO	0
what	what	WP	0
has	has	VBZ	0
been	been	VBN	0
reported	reported	VBN	0
previously	previously	RB	0
for	for	IN	0
MDCK-D	MDCK-D	JJ	B-NP
1	1	CD	0
,	,	,	0
a	a	DT	0
madin	madin	NNP	B-NP
darby	darby	NNP	I-NP
canine	canine	JJ	I-NP
kidney	kidney	NN	I-NP
subclone	subclone	NN	I-NP
selected	selected	VBD	0
for	for	IN	0
adrenergic	adrenergic	JJ	B-NP
receptor	receptor	NN	I-NP
expression	expression	NN	I-NP
[	[	-LRB-	0
39	39	CD	0
40	40	CD	0
]	]	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
a	a	DT	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
side-by-side	side-by-side	JJ	I-NP
comparison	comparison	NN	I-NP
from	from	IN	0
ATCC	ATCC	NNP	B-NP
and	and	CC	0
the	the	DT	0
MDCK-D	MDCK-D	JJ	B-NP
1	1	CD	0
subclona	subclona	NN	B-NP
(	(	-LRB-	0
kindly	kindly	RB	0
provided	provided	VBN	0
by	by	IN	0
Dr.	Dr.	NNP	B-NP
Paul	Paul	NNP	B-NP
Insel	Insel	NNP	I-NP
,	,	,	0
UCSD	UCSD	NNP	B-NP
)	)	-RRB-	0
demonstrated	demonstrated	VBD	0
constitutive	constitutive	JJ	B-NP
activation	activation	NN	I-NP
of	of	IN	0
ERKs	ERKs	JJ	0
when	when	WRB	0
both	both	DT	0
are	are	VBP	0
grown	grown	VBN	0
at	at	IN	0
low	low	JJ	0
density	density	NNS	0
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
However	However	RB	0
,	,	,	0
at	at	IN	0
high	high	JJ	0
density	density	NN	B-NP
erk	erk	NN	I-NP
are	are	VBP	0
less	less	RBR	0
active	active	JJ	0
and	and	CC	0
can	can	MD	0
be	be	VB	0
further	further	RB	0
activated	activated	VBN	0
by	by	IN	0
phorbol	phorbol	JJ	B-NP
ester	ester	NN	I-NP
(	(	-LRB-	0
not	not	RB	0
shown	shown	VBN	0
)	)	-RRB-	0
.	.	.	0
In	In	IN	0
MDCK-D	MDCK-D	JJ	0
1	1	CD	0
cells	cells	NNS	0
,	,	,	0
without	without	IN	0
constitutively	constitutively	JJ	0
active	active	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
AA	AA	NN	B-NP
release	release	NN	I-NP
is	is	VBZ	0
delayed	delayed	VBN	0
after	after	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization	mobilization	NN	B-NP
,	,	,	0
and	and	CC	0
is	is	VBZ	0
temporally	temporally	JJ	B-NP
correlated	correlated	NN	I-NP
with	with	IN	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
[	[	-LRB-	0
40	40	CD	0
]	]	-RRB-	0
,	,	,	0
whereas	whereas	VBG	0
in	in	IN	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
with	with	IN	0
constitutively	constitutively	JJ	0
active	active	JJ	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
,	,	,	0
AA	AA	NN	B-NP
release	release	NN	I-NP
is	is	VBZ	0
rapid	rapid	JJ	0
,	,	,	0
with	with	IN	0
significant	significant	JJ	0
AA	AA	NN	B-NP
release	release	NN	I-NP
measured	measured	VBD	0
30	30	CD	0
s	s	NN	0
after	after	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
This	This	DT	0
temporal	temporal	JJ	B-NP
correlation	correlation	NN	I-NP
between	between	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
and	and	CC	0
ERK	ERK	NNP	B-NP
activation	activation	NN	I-NP
has	has	VBZ	0
also	also	RB	0
been	been	VBN	0
reported	reported	VBN	0
in	in	IN	0
cho	cho	NNP	B-NP
cell	cell	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
PAF	PAF	NNP	B-NP
stimulation	stimulation	NN	I-NP
[	[	-LRB-	0
35	35	CD	0
41	41	CD	0
]	]	-RRB-	0
.	.	.	0
These	These	DT	0
results	results	NNS	0
support	support	VBP	0
the	the	DT	0
observation	observation	NN	B-NP
made	made	VBD	0
here	here	RB	0
that	that	IN	0
ERK	ERK	NNP	B-NP
activity	activity	NN	I-NP
is	is	VBZ	0
required	required	VBN	0
for	for	IN	0
phospholipid	phospholipid	JJ	B-NP
hydrolysi	hydrolysi	NN	I-NP
independently	independently	RB	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation.	translocation.	CD	B-NP
cPLA	cPLA	JJ	0
2	2	CD	0
-mediated	-mediated	JJ	0
AA	AA	NN	0
release	release	NN	0
must	must	MD	0
be	be	VB	0
preceded	preceded	VBN	0
by	by	IN	0
enzyme	enzyme	NN	B-NP
translocation	translocation	NN	I-NP
to	to	TO	0
its	its	PRP$	0
membrane	membrane	JJ	0
substrate	substrate	NN	0
which	which	WDT	0
is	is	VBZ	0
a	a	DT	0
Ca	Ca	NNP	B-NP
2+-dependent	2+-dependent	NNP	0
process	process	NN	0
and	and	CC	0
is	is	VBZ	0
a	a	DT	0
function	function	NN	0
of	of	IN	0
the	the	DT	0
calcium-dependent	calcium-dependent	JJ	B-NP
lipid-binding	lipid-binding	NN	I-NP
(	(	-LRB-	0
C2	C2	NNP	0
)	)	-RRB-	0
domain.	domain.	NNP	0
cPLA	cPLA	NNP	B-NP
2	2	CD	0
translocate	translocate	NN	B-NP
primarily	primarily	RB	0
to	to	TO	0
Golgi	Golgi	NNP	B-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
a	a	DT	0
transient	transient	NN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
changes	changes	NNS	0
and	and	CC	0
to	to	TO	0
Golgi	Golgi	NNP	B-NP
and	and	CC	0
endoplasmic	endoplasmic	NN	B-NP
reticulum	reticulum	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
a	a	DT	0
sustained	sustained	JJ	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
reduction	reduction	NN	0
in	in	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
by	by	IN	0
MEK	MEK	NNP	B-NP
inhibition	inhibition	NN	I-NP
did	did	VBD	0
not	not	RB	0
involve	involve	VB	0
a	a	DT	0
failure	failure	NN	0
in	in	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
release	release	NN	0
or	or	CC	0
translocation	translocation	NN	B-NP
.	.	.	0
These	These	DT	0
results	results	NNS	0
show	show	VBP	0
that	that	DT	0
translocation	translocation	NN	B-NP
is	is	VBZ	0
necessary	necessary	JJ	0
but	but	CC	0
not	not	RB	0
sufficient	sufficient	JJ	0
for	for	IN	0
hydrolytic	hydrolytic	JJ	B-NP
activity	activity	NN	I-NP
optimum	optimum	JJ	I-NP
.	.	.	0
Measuring	Measuring	VBG	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	NN	B-NP
is	is	VBZ	0
not	not	RB	0
a	a	DT	0
trivial	trivial	JJ	0
matter	matter	NN	0
when	when	WRB	0
aa	aa	NN	B-NP
release	release	NN	I-NP
investigating	investigating	VBG	I-NP
mechanism	mechanism	NN	I-NP
.	.	.	0
For	For	IN	0
example	example	NN	0
,	,	,	0
cPLA	cPLA	JJ	0
2	2	CD	0
constructs	constructs	NN	0
with	with	IN	0
a	a	DT	0
S505A	S505A	CD	0
mutation	mutation	NNS	0
have	have	VBP	0
long	long	RB	0
been	been	VBN	0
recognized	recognized	VBN	0
as	as	IN	0
unable	unable	JJ	0
to	to	TO	0
support	support	VB	0
AA	AA	NN	B-NP
release	release	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
physiological	physiological	VB	B-NP
agonist	agonist	NN	I-NP
or	or	CC	0
low-dose	low-dose	JJ	B-NP
ionophore	ionophore	NN	I-NP
when	when	WRB	0
transfected	transfected	NN	B-NP
in	in	IN	0
cells	cells	NNS	0
.	.	.	0
In	In	IN	0
contrast	contrast	NN	0
,	,	,	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
is	is	VBZ	0
active	active	JJ	0
in	in	IN	0
vitro	vitro	NN	B-NP
and	and	CC	0
phosphorylation	phosphorylation	VBP	0
only	only	RB	0
modestly	modestly	RB	0
increases	increases	VBZ	0
the	the	DT	0
activity	activity	NN	0
of	of	IN	0
the	the	DT	0
enzyme	enzyme	NN	B-NP
[	[	-LRB-	0
16	16	CD	0
17	17	CD	0
24	24	CD	0
]	]	-RRB-	0
.	.	.	0
Interestingly	Interestingly	RB	0
,	,	,	0
the	the	DT	0
inhibitory	inhibitory	JJ	B-NP
effect	effect	NN	I-NP
of	of	IN	0
the	the	DT	0
S505A	S505A	JJ	0
mutation	mutation	NN	0
on	on	IN	0
AA	AA	NN	B-NP
release	release	NN	I-NP
is	is	VBZ	0
obviated	obviated	VBN	0
by	by	IN	0
a	a	DT	0
high	high	JJ	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
.	.	.	0
In	In	IN	0
light	light	NN	0
of	of	IN	0
these	these	DT	0
observation	observation	NN	B-NP
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
Ser	Ser	NNP	0
505phosphorylation	505phosphorylation	NNP	0
may	may	MD	0
alter	alter	VB	0
the	the	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
sensitivity	sensitivity	FW	0
of	of	IN	0
the	the	DT	0
enzyme	enzyme	NN	B-NP
,	,	,	0
its	its	PRP$	0
rate	rate	NN	0
of	of	IN	0
translocation	translocation	NN	B-NP
,	,	,	0
its	its	PRP$	0
intracellular	intracellular	JJ	B-NP
targeting	targeting	NN	I-NP
or	or	CC	0
,	,	,	0
as	as	RB	0
has	has	VBZ	0
been	been	VBN	0
previously	previously	RB	0
suggested	suggested	VBD	0
[	[	-LRB-	0
22	22	CD	0
]	]	-RRB-	0
,	,	,	0
the	the	DT	0
ability	ability	NN	B-NP
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
to	to	TO	0
release	release	VB	0
from	from	IN	0
a	a	DT	0
non-membrane	non-membrane	JJ	B-NP
sequestering	sequestering	JJ	0
agent	agent	NN	B-NP
.	.	.	0
Although	Although	IN	0
one	one	CD	0
report	report	NN	0
has	has	VBZ	0
shown	shown	VBN	0
that	that	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
translocates	translocates	NN	0
in	in	IN	0
cho	cho	NNP	B-NP
cell	cell	NN	I-NP
in	in	IN	0
response	response	NN	0
to	to	TO	0
ionophore	ionophore	VB	0
,	,	,	0
we	we	PRP	0
were	were	VBD	0
able	able	JJ	0
to	to	TO	0
directly	directly	RB	0
compare	compare	VB	0
rates	rates	NNS	0
of	of	IN	0
translocation	translocation	NN	B-NP
between	between	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
to	to	TO	0
a	a	DT	0
physiological	physiological	JJ	B-NP
agonist	agonist	NN	I-NP
and	and	CC	0
found	found	VBD	0
no	no	DT	0
difference	difference	NN	0
between	between	IN	0
translocation	translocation	JJ	B-NP
rate	rate	NN	I-NP
or	or	CC	0
intracellular	intracellular	JJ	B-NP
targeting	targeting	NN	I-NP
.	.	.	0
We	We	PRP	0
also	also	RB	0
demonstrated	demonstrated	VBN	0
that	that	IN	0
there	there	EX	0
was	was	VBD	0
no	no	DT	0
difference	difference	NN	0
in	in	IN	0
translocation	translocation	JJ	B-NP
rate	rate	NN	I-NP
or	or	CC	0
intracellular	intracellular	VBP	0
targeting	targeting	VBG	0
between	between	IN	0
wild-type	wild-type	JJ	B-NP
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
,	,	,	0
which	which	WDT	0
has	has	VBZ	0
the	the	DT	0
same	same	JJ	0
phenotype	phenotype	NN	B-NP
as	as	IN	0
S505A	S505A	CD	0
with	with	IN	0
regard	regard	NN	0
to	to	TO	0
AA	AA	NN	B-NP
release	release	NN	I-NP
when	when	WRB	0
transfected	transfected	NN	B-NP
into	into	IN	0
cells	cells	NNS	0
.	.	.	0
Thus	Thus	RB	0
,	,	,	0
the	the	DT	0
role	role	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
phosphorylation	phosphorylation	NN	B-NP
in	in	IN	0
mediating	mediating	JJ	0
AA	AA	NN	B-NP
release	release	NN	I-NP
remains	remains	VBZ	0
unclear	unclear	JJ	0
.	.	.	0
Although	Although	IN	0
the	the	DT	0
alternative	alternative	JJ	0
mechanism	mechanism	NN	0
whereby	whereby	WRB	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
regulates	regulates	VBZ	0
cPLA	cPLA	JJ	0
2	2	CD	0
is	is	VBZ	0
not	not	RB	0
known	known	VBN	0
,	,	,	0
it	it	PRP	0
is	is	VBZ	0
possible	possible	JJ	0
that	that	IN	0
it	it	PRP	0
affects	affects	VBZ	0
membrane	membrane	JJ	B-NP
property	property	NN	I-NP
and	and	CC	0
/	/	NNP	0
or	or	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
conformation	conformation	NN	B-NP
that	that	WDT	0
promotes	promotes	VBZ	0
optimal	optimal	JJ	B-NP
hydrolytic	hydrolytic	JJ	I-NP
activity	activity	NN	I-NP
.	.	.	0
It	It	PRP	0
is	is	VBZ	0
also	also	RB	0
possible	possible	JJ	0
that	that	IN	0
the	the	DT	0
alternative	alternative	JJ	0
mechanism	mechanism	NN	0
is	is	VBZ	0
due	due	JJ	0
to	to	TO	0
phosphorylation	phosphorylation	VB	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
on	on	IN	0
a	a	DT	0
novel	novel	NN	0
site	site	NN	0
by	by	IN	0
a	a	DT	0
kinase	kinase	NN	B-NP
that	that	WDT	0
is	is	VBZ	0
downstream	downstream	VBN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	NN	I-NP
or	or	CC	0
regulatory	regulatory	JJ	B-NP
protein	protein	NN	I-NP
phosphorylation	phosphorylation	NN	I-NP
.	.	.	0
Conclusions	Conclusions	NNP	0
Translocation	Translocation	NNP	B-NP
to	to	TO	0
membrane	membrane	NN	0
is	is	VBZ	0
a	a	DT	0
critical	critical	JJ	B-NP
regulatory	regulatory	JJ	I-NP
step	step	NN	I-NP
for	for	IN	0
the	the	DT	0
action	action	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
because	because	IN	0
it	it	PRP	0
is	is	VBZ	0
necessary	necessary	JJ	0
for	for	IN	0
access	access	NN	0
to	to	TO	0
substrate	substrate	VB	0
.	.	.	0
In	In	IN	0
this	this	DT	0
study	study	NN	0
we	we	PRP	0
demonstrate	demonstrate	VBP	0
,	,	,	0
however	however	RB	0
,	,	,	0
that	that	DT	0
association	association	NN	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
with	with	IN	0
membrane	membrane	NN	0
when	when	WRB	0
phosphorylated	phosphorylated	NNS	0
on	on	IN	0
Ser	Ser	NNP	0
505is	505is	NNP	0
not	not	RB	0
sufficient	sufficient	JJ	0
for	for	IN	0
its	its	PRP$	0
full	full	JJ	0
activity	activity	NN	0
in	in	IN	0
vivo	vivo	NN	B-NP
.	.	.	0
This	This	DT	0
is	is	VBZ	0
demonstrated	demonstrated	VBN	0
by	by	IN	0
the	the	DT	0
results	results	NNS	0
showing	showing	VBG	0
that	that	DT	0
inhibition	inhibition	NN	0
of	of	IN	0
the	the	DT	0
MEK1	MEK1	NNP	B-NP
/	/	NNP	0
ERK	ERK	NNP	B-NP
pathway	pathway	VBD	I-NP
significantly	significantly	RB	0
blocks	blocks	JJ	0
AA	AA	NN	B-NP
release	release	NN	I-NP
but	but	CC	0
has	has	VBZ	0
no	no	DT	0
effect	effect	NN	0
on	on	IN	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
mobilization	mobilization	NN	B-NP
or	or	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
translocation	translocation	NN	B-NP
and	and	CC	0
targeting	targeting	VBG	0
.	.	.	0
Diminution	Diminution	NNP	0
of	of	IN	0
AA	AA	NN	0
release	release	NN	0
by	by	IN	0
MEK1	MEK1	NNP	0
/	/	NNP	0
ERK	ERK	NNP	0
is	is	VBZ	0
also	also	RB	0
independent	independent	JJ	0
of	of	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
phosphorylation	phosphorylation	NN	0
on	on	IN	0
Ser	Ser	NNP	0
505	505	CD	0
.	.	.	0
Consequently	Consequently	RB	0
,	,	,	0
our	our	PRP$	0
results	results	NNS	0
demonstrate	demonstrate	VBP	0
in	in	IN	0
living	living	VBG	B-NP
cell	cell	NN	I-NP
that	that	IN	0
the	the	DT	0
translocation	translocation	JJ	B-NP
process	process	NN	I-NP
and	and	CC	0
subsequent	subsequent	JJ	0
catalytic	catalytic	JJ	B-NP
activity	activity	NN	I-NP
on	on	IN	0
the	the	DT	0
membrane	membrane	NNS	0
are	are	VBP	0
two	two	CD	0
independently	independently	RB	0
regulated	regulated	VBN	B-NP
step	step	NN	I-NP
.	.	.	0
Materials	Materials	NNS	0
and	and	CC	0
Methods	Methods	NNP	0
Fluorescent	Fluorescent	NNP	0
protein-cPLA	protein-cPLA	NNP	0
2fusion	2fusion	NNP	0
constructs	constructs	VBD	0
DNA	DNA	NNP	0
encoding	encoding	VBD	0
the	the	DT	0
full-length	full-length	JJ	0
human	human	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
was	was	VBD	0
cloned	cloned	VBN	0
into	into	IN	0
the	the	DT	0
vector	vector	JJ	0
pEGFP-C3	pEGFP-C3	NNP	0
(	(	-LRB-	0
Clontech	Clontech	NNP	0
)	)	-RRB-	0
to	to	TO	0
create	create	VB	0
pEGFP-cPLA	pEGFP-cPLA	JJ	0
2	2	CD	0
,	,	,	0
as	as	RB	0
previously	previously	RB	0
described	described	VBN	0
[	[	-LRB-	0
15	15	CD	0
]	]	-RRB-	0
.	.	.	0
The	The	DT	0
XbaI	XbaI	JJ	B-NP
/	/	CD	I-NP
PstI	PstI	JJ	I-NP
fragment	fragment	NN	I-NP
from	from	IN	0
a	a	DT	0
cPLA	cPLA	JJ	0
2	2	CD	0
α	α	NNS	0
clone	clone	VBP	0
containing	containing	VBG	0
S505A	S505A	NNP	0
or	or	CC	0
S727A	S727A	CD	0
mutations	mutations	NNS	0
[	[	-LRB-	0
13	13	CD	0
]	]	-RRB-	0
was	was	VBD	0
inserted	inserted	VBN	0
into	into	IN	0
an	an	DT	0
XbaI	XbaI	JJ	B-NP
/	/	CD	I-NP
PstI	PstI	JJ	I-NP
site	site	NN	I-NP
in	in	IN	0
pEGFP-cPLA	pEGFP-cPLA	JJ	B-NP
2	2	CD	0
to	to	TO	0
generate	generate	VB	0
pEGFP-cPLA	pEGFP-cPLA	JJ	B-NP
2	2	CD	0
S505A	S505A	CD	0
and	and	CC	0
pECFP-cPLA	pECFP-cPLA	JJ	B-NP
2	2	CD	0
S727A	S727A	CD	0
.	.	.	0
Different	Different	JJ	B-NP
fluorescent-protein	fluorescent-protein	JJ	I-NP
tagged	tagged	JJ	0
constructs	constructs	NN	0
were	were	VBD	0
produced	produced	VBN	0
by	by	IN	0
exchanging	exchanging	VBG	0
the	the	DT	0
NheI	NheI	JJ	B-NP
/	/	CD	I-NP
BsrGI	BsrGI	JJ	I-NP
fragment	fragment	NN	I-NP
containing	containing	VBG	0
the	the	DT	0
fluorescent	fluorescent	JJ	0
protein	protein	NN	0
coding	coding	NN	0
sequence	sequence	NN	0
between	between	IN	0
EGFP	EGFP	NNP	B-NP
,	,	,	0
EYFP	EYFP	NNP	B-NP
,	,	,	0
and	and	CC	0
ECFP	ECFP	NNP	B-NP
.	.	.	0
All	All	DT	0
constructs	constructs	NN	0
were	were	VBD	0
confirmed	confirmed	VBN	0
by	by	IN	0
sequencing	sequencing	NN	B-NP
.	.	.	0
cell	cell	NN	B-NP
culture	culture	NN	I-NP
mdck	mdck	NN	I-NP
cell	cell	NN	I-NP
obtained	obtained	VBN	0
from	from	IN	0
ATCC	ATCC	NNP	B-NP
were	were	VBD	0
cultured	cultured	VBN	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
10	10	CD	0
%	%	NN	0
fetal	fetal	JJ	B-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
		NN	I-NP
bovine	bovine	JJ	I-NP
serum	serum	NN	I-NP
,	,	,	0
100	100	CD	0
U	U	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
penicillin	penicillin	NN	I-NP
,	,	,	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
streptomycin	streptomycin	NN	I-NP
,	,	,	0
0.292	0.292	FW	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
glutamine	glutamine	NN	I-NP
(	(	-LRB-	0
growth	growth	NN	B-NP
medium	medium	NN	I-NP
)	)	-RRB-	0
in	in	IN	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
subconfluent	subconfluent	NN	B-NP
cell	cell	NN	I-NP
(	(	-LRB-	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
3cells	3cells	CD	0
/	/	CD	0
cm	cm	CD	0
2	2	CD	0
)	)	-RRB-	0
were	were	VBD	0
transfected	transfected	VBN	0
with	with	IN	0
2	2	CD	0
μg	μg	NN	B-NP
of	of	IN	0
the	the	DT	0
relevant	relevant	JJ	0
plasmid	plasmid	NN	B-NP
using	using	VBG	0
Fugene-6	Fugene-6	NNP	B-NP
(	(	-LRB-	0
Boehringer	Boehringer	NNP	0
Mannheim	Mannheim	NNP	0
)	)	-RRB-	0
in	in	IN	0
DMEM	DMEM	NNP	B-NP
containing	containing	VBG	0
0.2	0.2	CD	0
%	%	NN	0
BSA	BSA	NNP	B-NP
,	,	,	0
100	100	CD	0
U	U	NNP	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
penicillin	penicillin	NN	I-NP
,	,	,	0
100	100	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
streptomycin	streptomycin	NN	I-NP
,	,	,	0
0.292	0.292	FW	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
glutamine	glutamine	NN	I-NP
(	(	-LRB-	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
)	)	-RRB-	0
following	following	VBG	0
the	the	DT	0
manufacturer	manufacturer	NN	0
's	's	POS	0
protocol	protocol	NN	0
.	.	.	0
Stable	Stable	JJ	0
lines	lines	NNS	0
expressing	expressing	VBG	B-NP
EGFP-cPLA	EGFP-cPLA	JJ	I-NP
2	2	CD	0
were	were	VBD	0
generated	generated	VBN	0
by	by	IN	0
growing	growing	VBG	0
transfected	transfected	JJ	B-NP
cell	cell	NN	I-NP
in	in	IN	0
growth	growth	NN	B-NP
medium	medium	NN	I-NP
for	for	IN	0
3	3	CD	0
d	d	NN	0
,	,	,	0
supplementing	supplementing	VBG	0
the	the	DT	0
growth	growth	NN	B-NP
medium	medium	NN	I-NP
with	with	IN	0
5	5	CD	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
Geneticin	Geneticin	NN	I-NP
(	(	-LRB-	0
antibiotic	antibiotic	JJ	B-NP
G418-sulfate	G418-sulfate	NN	I-NP
)	)	-RRB-	0
,	,	,	0
and	and	CC	0
culturing	culturing	NN	B-NP
for	for	IN	0
an	an	DT	0
additional	additional	JJ	0
2	2	CD	0
wk	wk	NN	B-NP
in	in	IN	0
Geneticin	Geneticin	NNP	B-NP
.	.	.	0
Cells	Cells	NNS	0
expressing	expressing	VBG	B-NP
EGFP	EGFP	NNP	I-NP
fluorescence	fluorescence	NN	I-NP
were	were	VBD	0
selected	selected	VBN	0
using	using	VBG	0
a	a	DT	0
fluorescence-activated	fluorescence-activated	JJ	0
cell	cell	NN	0
sorter	sorter	NN	0
.	.	.	0
The	The	DT	0
egfp-positive	egfp-positive	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
maintained	maintained	VBN	0
in	in	IN	0
growth	growth	NN	B-NP
medium	medium	NN	I-NP
supplemented	supplemented	NN	I-NP
with	with	IN	0
5	5	CD	0
mg	mg	NN	B-NP
/	/	NN	I-NP
ml	ml	NN	I-NP
Geneticin	Geneticin	NN	I-NP
.	.	.	0
For	For	IN	0
imaging	imaging	JJ	0
studies	studies	NNS	0
,	,	,	0
mdck	mdck	NN	B-NP
cell	cell	NN	I-NP
were	were	VBD	0
plated	plated	VBN	0
on	on	IN	0
glass-bottomed	glass-bottomed	JJ	0
35	35	CD	0
mm	mm	JJ	0
culture	culture	NN	0
dishes	dishes	NNS	0
(	(	-LRB-	0
MatTek	MatTek	NNP	B-NP
)	)	-RRB-	0
at	at	IN	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
3cells	3cells	CD	0
/	/	CD	0
cm	cm	CD	0
2in	2in	CD	B-NP
growth	growth	NN	I-NP
medium	medium	NN	I-NP
and	and	CC	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
,	,	,	0
transfected	transfected	VBG	0
with	with	IN	0
the	the	DT	0
relevant	relevant	JJ	0
plasmid	plasmid	NNS	B-NP
,	,	,	0
changed	changed	VBN	0
into	into	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
to	to	TO	0
quiesce	quiesce	VB	0
the	the	DT	0
cells	cells	NNS	0
,	,	,	0
incubated	incubated	JJ	0
overnight	overnight	JJ	0
,	,	,	0
and	and	CC	0
used	used	VBD	0
the	the	DT	0
next	next	JJ	0
day	day	NN	0
.	.	.	0
Immunoblotting	Immunoblotting	NNP	B-NP
Stable	Stable	NNP	I-NP
EGFP-cPLA	EGFP-cPLA	NNP	I-NP
2	2	CD	0
transfectant	transfectant	NN	B-NP
were	were	VBD	0
grown	grown	VBN	0
on	on	IN	0
100	100	CD	0
mm	mm	CD	0
dishes	dishes	NNS	0
at	at	IN	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
3cells	3cells	CD	0
/	/	CD	0
cm	cm	CD	0
2in	2in	CD	B-NP
growth	growth	NN	I-NP
medium	medium	NN	I-NP
for	for	IN	0
one	one	CD	0
day	day	NN	0
,	,	,	0
then	then	RB	0
quiesced	quiesced	VBN	0
in	in	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
overnight	overnight	RB	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
scraped	scraped	VBN	0
into	into	IN	0
lysis	lysis	JJ	B-NP
buffer	buffer	NN	I-NP
ice-cold	ice-cold	JJ	I-NP
:	:	:	0
50	50	CD	0
mm	mm	NN	B-NP
hepe	hepe	NN	I-NP
,	,	,	0
pH	pH	JJ	0
7.4	7.4	CD	0
,	,	,	0
150	150	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
chloride	chloride	NN	I-NP
,	,	,	0
1.5	1.5	CD	0
mM	mM	JJ	B-NP
magnesium	magnesium	JJ	I-NP
chloride	chloride	NN	I-NP
,	,	,	0
10	10	CD	0
%	%	NN	0
glycerol	glycerol	NN	B-NP
,	,	,	0
1	1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
EGTA	EGTA	NNP	I-NP
,	,	,	0
200	200	CD	0
μM	μM	JJ	B-NP
sodium	sodium	JJ	I-NP
vanadate	vanadate	NN	I-NP
,	,	,	0
10	10	CD	0
mM	mM	JJ	0
tetrasodium	tetrasodium	JJ	B-NP
pyrophosphate	pyrophosphate	NN	I-NP
,	,	,	0
100	100	CD	0
mM	mM	JJ	B-NP
sodium	sodium	JJ	I-NP
fluoride	fluoride	NN	I-NP
,	,	,	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	JJ	I-NP
leupeptin	leupeptin	NN	I-NP
,	,	,	0
and	and	CC	0
10	10	CD	0
μg	μg	CD	B-NP
/	/	CD	I-NP
ml	ml	CD	I-NP
aprotinin	aprotinin	NN	I-NP
.	.	.	0
lysate	lysate	NN	B-NP
were	were	VBD	0
centrifuged	centrifuged	VBN	0
at	at	IN	0
15,000	15,000	CD	0
×	×	CD	0
g	g	NN	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
,	,	,	0
and	and	CC	0
supernatant	supernatant	NN	B-NP
protein	protein	NN	I-NP
concentration	concentration	NN	I-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
the	the	DT	0
bicinchoninic	bicinchoninic	JJ	B-NP
acid	acid	NN	I-NP
method	method	NN	I-NP
.	.	.	0
Laemmli	Laemmli	NN	B-NP
electrophoresi	electrophoresi	NN	I-NP
sample	sample	NN	I-NP
buffer	buffer	NN	I-NP
(	(	-LRB-	0
5×	5×	NNP	0
)	)	-RRB-	0
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
the	the	DT	0
lysate	lysate	NN	B-NP
,	,	,	0
and	and	CC	0
sds-polyacrylamide	sds-polyacrylamide	NN	B-NP
gel	gel	JJ	I-NP
electrophoresi	electrophoresi	NN	I-NP
and	and	CC	0
immunoblotting	immunoblotting	NN	B-NP
were	were	VBD	0
performed	performed	VBN	0
using	using	VBG	0
35	35	CD	0
μg	μg	CD	B-NP
lysate	lysate	JJ	I-NP
protein	protein	NN	I-NP
,	,	,	0
extracellular	extracellular	NN	B-NP
signal	signal	JJ	I-NP
regulated	regulated	VBN	I-NP
kinase	kinase	NN	I-NP
phospho-specific	phospho-specific	JJ	I-NP
antibody	antibody	NN	I-NP
and	and	CC	0
p38	p38	NNP	B-NP
,	,	,	0
and	and	CC	0
rabbit	rabbit	JJ	0
polyclonal	polyclonal	JJ	B-NP
antibody	antibody	NN	I-NP
for	for	IN	0
cPLA	cPLA	JJ	0
2	2	CD	0
[	[	-LRB-	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
Dual	Dual	JJ	0
imaging	imaging	NN	0
microscopy	microscopy	NN	0
of	of	IN	0
fluorescent	fluorescent	JJ	0
protein	protein	NN	0
translocation	translocation	NN	0
In	In	IN	0
order	order	NN	0
to	to	TO	0
compare	compare	VB	0
the	the	DT	0
characteristics	characteristics	NN	0
of	of	IN	0
full-length	full-length	JJ	0
cPLA	cPLA	JJ	0
2	2	CD	0
and	and	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
S505A	S505A	CD	0
or	or	CC	0
cPLA	cPLA	JJ	0
2	2	CD	0
S727A	S727A	CD	0
translocation	translocation	NN	0
,	,	,	0
while	while	IN	0
controlling	controlling	VBG	0
for	for	IN	0
cell-to-cell	cell-to-cell	JJ	0
heterogeneity	heterogeneity	NN	0
,	,	,	0
we	we	PRP	0
used	used	VBD	0
a	a	DT	0
dual	dual	JJ	0
CFP	CFP	NNP	0
/	/	NNP	0
YFP	YFP	NNP	0
imaging	imaging	NN	0
approach	approach	NN	0
.	.	.	0
EYFP-cPLA	EYFP-cPLA	JJ	0
2	2	CD	0
/	/	CD	0
ECFP-cPLA	ECFP-cPLA	JJ	0
2	2	CD	0
S505A-	S505A-	CD	0
or	or	CC	0
pECFP-cPLA	pECFP-cPLA	JJ	0
2	2	CD	0
S727A-transfected	S727A-transfected	CD	0
MDCK	MDCK	NN	0
cells	cells	NNS	0
grown	grown	VBN	0
on	on	IN	0
MatTek	MatTek	JJ	0
plates	plates	NN	0
were	were	VBD	0
quiesced	quiesced	JJ	0
overnight	overnight	JJ	0
in	in	IN	0
serum-free	serum-free	JJ	0
medium	medium	NN	0
,	,	,	0
washed	washed	VBN	0
with	with	IN	0
and	and	CC	0
incubated	incubated	NN	0
in	in	IN	0
Hank	Hank	NNP	0
's	's	POS	0
balanced	balanced	JJ	0
salt	salt	NN	0
solution	solution	NN	0
(	(	-LRB-	0
HBSS	HBSS	NNP	0
)	)	-RRB-	0
additionally	additionally	RB	0
buffered	buffered	VBN	0
with	with	IN	0
25	25	CD	0
mM	mM	JJ	0
HEPES	HEPES	NNP	0
pH	pH	NNP	0
7.4	7.4	CD	0
(	(	-LRB-	0
HHBSS	HHBSS	NNP	0
)	)	-RRB-	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
imaged	imaged	VBN	0
using	using	VBG	0
an	an	DT	0
Olympus	Olympus	JJ	0
inverted	inverted	NNS	0
microscope	microscope	VBP	0
equipped	equipped	VBN	0
with	with	IN	0
a	a	DT	0
60×	60×	NNP	0
,	,	,	0
1.25	1.25	CD	0
NA	NA	JJ	0
oil	oil	NN	0
immersion	immersion	NN	0
objective	objective	NN	0
,	,	,	0
CFP	CFP	NNP	0
and	and	CC	0
YFP	YFP	NNP	0
emission	emission	NN	0
filters	filters	NNS	0
(	(	-LRB-	0
Chroma	Chroma	NNP	0
)	)	-RRB-	0
in	in	IN	0
a	a	DT	0
Sutter	Sutter	JJ	0
filter	filter	JJ	0
wheel	wheel	NN	0
,	,	,	0
a	a	DT	0
dual	dual	JJ	0
CFP	CFP	NNP	0
/	/	NNP	0
YFP	YFP	NNP	0
dichroic	dichroic	JJ	0
mirror	mirror	NN	0
,	,	,	0
and	and	CC	0
a	a	DT	0
TILL	TILL	NNP	0
Imago	Imago	NNP	0
CCD	CCD	NNP	0
camera	camera	NN	0
(	(	-LRB-	0
TILL	TILL	NNP	0
Photonics	Photonics	NNP	0
)	)	-RRB-	0
.	.	.	0
Excitation	Excitation	JJ	0
light	light	NN	0
of	of	IN	0
430	430	CD	0
and	and	CC	0
510	510	CD	0
nm	nm	NN	0
for	for	IN	0
CFP	CFP	NNP	0
and	and	CC	0
YFP	YFP	NNP	0
,	,	,	0
respectively	respectively	RB	0
,	,	,	0
was	was	VBD	0
provided	provided	VBN	0
using	using	VBG	0
a	a	DT	0
Polychrome	Polychrome	NNP	0
IV	IV	NNP	0
monochromator	monochromator	NNS	0
(	(	-LRB-	0
TILL	TILL	NNP	0
Photonics	Photonics	NNP	0
)	)	-RRB-	0
.	.	.	0
TILLvisION	TILLvisION	JJ	0
software	software	NN	0
was	was	VBD	0
used	used	VBN	0
for	for	IN	0
acquisition	acquisition	NN	0
and	and	CC	0
analysis	analysis	NN	0
.	.	.	0
Bleach	Bleach	JJ	0
values	values	NNS	0
for	for	IN	0
ECFP	ECFP	NNP	0
and	and	CC	0
EYFP	EYFP	NNP	0
were	were	VBD	0
calculated	calculated	VBN	0
by	by	IN	0
determining	determining	VBG	0
the	the	DT	0
background-corrected	background-corrected	JJ	0
fluorescence	fluorescence	NN	0
for	for	IN	0
the	the	DT	0
entire	entire	JJ	0
cell	cell	NN	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
time	time	NN	0
and	and	CC	0
normalizing	normalizing	VBG	0
each	each	DT	0
value	value	NN	0
to	to	TO	0
the	the	DT	0
initial	initial	JJ	0
value	value	NN	0
.	.	.	0
ECFP	ECFP	NNP	0
/	/	NNP	0
EYFP	EYFP	NNP	0
fluorescence	fluorescence	NN	0
changes	changes	NNS	0
with	with	IN	0
respect	respect	NN	0
to	to	TO	0
time	time	NN	0
for	for	IN	0
regions	regions	NNS	0
of	of	IN	0
interest	interest	NN	0
corresponding	corresponding	NN	0
to	to	TO	0
an	an	DT	0
area	area	NN	0
of	of	IN	0
Golgi	Golgi	NNP	0
membrane	membrane	NN	0
were	were	VBD	0
determined	determined	VBN	0
by	by	IN	0
calculating	calculating	VBG	0
the	the	DT	0
F	F	NN	0
t	t	VBD	0
/	/	CD	0
F	F	NN	0
0	0	CD	0
,	,	,	0
where	where	WRB	0
F	F	NN	0
t	t	NN	0
is	is	VBZ	0
the	the	DT	0
background-	background-	JJ	0
and	and	CC	0
bleach-corrected	bleach-corrected	NNP	0
ECFP	ECFP	NNP	0
or	or	CC	0
EYFP	EYFP	NNP	0
fluorescence	fluorescence	NN	0
at	at	IN	0
time	time	NN	0
=	=	SYM	0
t	t	FW	0
and	and	CC	0
F	F	NNP	0
0	0	CD	0
is	is	VBZ	0
the	the	DT	0
background-corrected	background-corrected	JJ	0
ECFP	ECFP	NNP	0
or	or	CC	0
EYFP	EYFP	NNP	0
fluorescence	fluorescence	NN	0
at	at	IN	0
time	time	NN	0
=	=	SYM	0
0	0	CD	0
s	s	NNS	0
.	.	.	0
Fluorescence	Fluorescence	NNP	0
was	was	VBD	0
normalized	normalized	VBN	0
to	to	TO	0
the	the	DT	0
F	F	NN	0
0	0	CD	0
value	value	NN	0
,	,	,	0
which	which	WDT	0
resulted	resulted	VBD	0
in	in	IN	0
F	F	NN	0
t	t	VBD	0
/	/	CD	0
F	F	NN	0
0	0	CD	0
representing	representing	VBG	0
the	the	DT	0
fraction	fraction	NN	0
of	of	IN	0
total	total	JJ	0
cell	cell	NN	0
fluorescence	fluorescence	NN	0
at	at	IN	0
Golgi	Golgi	NNP	0
.	.	.	0
Final	Final	JJ	0
images	images	NNS	0
were	were	VBD	0
produced	produced	VBN	0
using	using	VBG	0
Adobe	Adobe	NNP	0
Photoshop	Photoshop	NNP	0
.	.	.	0
calcium	calcium	NN	B-NP
imaging	imaging	NN	I-NP
mdck	mdck	NN	I-NP
cell	cell	NN	I-NP
grown	grown	VBN	0
on	on	IN	0
mattek	mattek	NN	B-NP
plate	plate	NN	I-NP
were	were	VBD	0
quiesced	quiesced	JJ	B-NP
overnight	overnight	JJ	I-NP
in	in	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
,	,	,	0
washed	washed	VBN	0
with	with	IN	0
hhb	hhb	NN	B-NP
containing	containing	VBG	0
1	1	CD	0
mM	mM	JJ	B-NP
probenecid	probenecid	NN	I-NP
and	and	CC	0
incubated	incubated	NN	0
with	with	IN	0
5	5	CD	0
μM	μM	JJ	B-NP
Fura2-AM	Fura2-AM	NNP	I-NP
(	(	-LRB-	0
Calbiochem	Calbiochem	NNP	B-NP
)	)	-RRB-	0
in	in	IN	0
hhb	hhb	NN	B-NP
,	,	,	0
1	1	CD	0
mM	mM	JJ	B-NP
probenecid	probenecid	NN	I-NP
,	,	,	0
and	and	CC	0
1	1	CD	0
%	%	NN	0
DMSO	DMSO	NN	B-NP
for	for	IN	0
45	45	CD	0
min	min	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
then	then	RB	0
washed	washed	VBN	0
with	with	IN	0
hhb	hhb	NN	B-NP
containing	containing	VBG	0
1	1	CD	0
mM	mM	JJ	B-NP
probenecid	probenecid	NN	I-NP
and	and	CC	0
imaged	imaged	NN	0
after	after	IN	0
a	a	DT	0
30	30	CD	0
fura2-am	fura2-am	NN	B-NP
de-esterification	de-esterification	JJ	I-NP
min	min	JJ	I-NP
incubation	incubation	NN	I-NP
.	.	.	0
Single-cell	Single-cell	JJ	B-NP
imaging	imaging	NN	I-NP
was	was	VBD	0
performed	performed	VBN	0
on	on	IN	0
the	the	DT	0
Olympus	Olympus	JJ	B-NP
system	system	NN	I-NP
described	described	VBD	0
above	above	RB	0
,	,	,	0
but	but	CC	0
using	using	VBG	0
a	a	DT	0
40×	40×	NNP	0
,	,	,	0
1.35	1.35	CD	0
NA	NA	JJ	B-NP
oil	oil	NN	I-NP
immersion	immersion	NN	I-NP
objective	objective	NN	I-NP
and	and	CC	0
a	a	DT	0
Fura2	Fura2	JJ	B-NP
dichroic	dichroic	JJ	I-NP
mirror	mirror	NN	I-NP
and	and	CC	0
emission	emission	JJ	B-NP
filter	filter	NN	I-NP
(	(	-LRB-	0
Chroma	Chroma	NNP	B-NP
)	)	-RRB-	0
.	.	.	0
fura2	fura2	NN	B-NP
image	image	NN	I-NP
pair	pair	NN	I-NP
illuminated	illuminated	NN	0
at	at	IN	0
340	340	CD	0
and	and	CC	0
380	380	CD	0
nm	nm	NN	B-NP
were	were	VBD	0
taken	taken	VBN	0
at	at	IN	0
1	1	CD	0
Hz	Hz	NNP	B-NP
.	.	.	0
The	The	DT	0
[	[	-LRB-	0
Ca	Ca	NNP	B-NP
2+	2+	NNP	0
]	]	-RRB-	0
i	i	FW	0
increase	increase	NN	0
is	is	VBZ	0
expressed	expressed	VBN	0
as	as	IN	0
the	the	DT	0
ratio	ratio	NN	0
of	of	IN	0
the	the	DT	0
background-corrected	background-corrected	JJ	0
Fura2	Fura2	CD	B-NP
fluorescence	fluorescence	NN	I-NP
at	at	IN	0
340	340	CD	0
and	and	CC	0
380	380	CD	0
nm	nm	NN	B-NP
[	[	-LRB-	0
42	42	CD	0
]	]	-RRB-	0
.	.	.	0
Measurement	Measurement	NN	0
of	of	IN	0
AA	AA	NN	0
release	release	NN	0
The	The	DT	0
protocol	protocol	NN	0
for	for	IN	0
determining	determining	VBG	0
AA	AA	NN	0
release	release	NN	0
is	is	VBZ	0
essentially	essentially	RB	0
as	as	RB	0
described	described	VBN	0
[	[	-LRB-	0
15	15	CD	0
21	21	CD	0
]	]	-RRB-	0
.	.	.	0
MDCK	MDCK	NNP	0
cells	cells	NNS	0
stably	stably	VBP	0
expressing	expressing	VBG	0
EGFP-cPLA	EGFP-cPLA	JJ	0
2	2	CD	0
were	were	VBD	0
plated	plated	VBN	0
in	in	IN	0
12-well	12-well	CD	0
plates	plates	NN	0
at	at	IN	0
5	5	CD	0
×	×	CD	0
10	10	CD	0
3cells	3cells	CD	0
/	/	CD	0
cm	cm	CD	0
2and	2and	CD	0
incubated	incubated	NN	0
in	in	IN	0
growth	growth	NN	0
medium	medium	NN	0
overnight	overnight	RB	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
then	then	RB	0
washed	washed	VBN	0
twice	twice	RB	0
with	with	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
and	and	CC	0
incubated	incubated	NN	0
with	with	IN	0
0.25	0.25	CD	0
μus	μus	NN	B-NP
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
-AA	-AA	NNP	0
/	/	NNP	0
well	well	RB	0
in	in	IN	0
serum-free	serum-free	JJ	B-NP
medium	medium	NN	I-NP
overnight	overnight	RB	0
.	.	.	0
U0126	U0126	NNP	0
or	or	CC	0
vehicle	vehicle	NN	B-NP
was	was	VBD	0
added	added	VBN	0
to	to	TO	0
each	each	DT	0
well	well	RB	0
and	and	CC	0
the	the	DT	0
cells	cells	NNS	0
were	were	VBD	0
then	then	RB	0
incubated	incubated	VBN	0
for	for	IN	0
15	15	CD	0
min	min	NN	B-NP
at	at	IN	0
37°C	37°C	CD	0
in	in	IN	0
5	5	CD	0
%	%	NN	0
CO	CO	NNP	0
2	2	CD	0
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
washed	washed	VBN	0
to	to	TO	0
remove	remove	VB	0
unincorporated	unincorporated	NNS	0
[	[	-LRB-	0
3H	3H	NNP	0
]	]	-RRB-	0
-AA	-AA	JJ	0
and	and	CC	0
then	then	RB	0
incubated	incubated	VBN	0
in	in	IN	0
HHBSS	HHBSS	NNP	B-NP
supplemented	supplemented	NN	I-NP
with	with	IN	0
0.05	0.05	CD	0
%	%	NN	0
BSA	BSA	NN	B-NP
with	with	IN	0
either	either	DT	0
U0126	U0126	NNP	0
or	or	CC	0
vehicle	vehicle	NN	B-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
stimulated	stimulated	VBN	0
with	with	IN	0
the	the	DT	0
agonist	agonist	NN	B-NP
of	of	IN	0
choice	choice	NN	0
and	and	CC	0
the	the	DT	0
medium	medium	NN	0
was	was	VBD	0
collected	collected	VBN	0
at	at	IN	0
appropriate	appropriate	JJ	0
time	time	NN	B-NP
point	point	NN	I-NP
.	.	.	0
The	The	DT	0
medium	medium	NN	0
was	was	VBD	0
centrifuged	centrifuged	VBN	0
at	at	IN	0
500	500	CD	0
g	g	NN	0
for	for	IN	0
5	5	CD	0
min	min	NN	B-NP
,	,	,	0
and	and	CC	0
the	the	DT	0
amount	amount	NN	0
of	of	IN	0
radioactivity	radioactivity	NN	0
in	in	IN	0
the	the	DT	0
supernatant	supernatant	NN	B-NP
was	was	VBD	0
determined	determined	VBN	0
by	by	IN	0
scintillation	scintillation	JJ	B-NP
counting	counting	NN	I-NP
.	.	.	0
Cells	Cells	NNS	0
were	were	VBD	0
scraped	scraped	VBN	0
in	in	IN	0
0.5	0.5	CD	0
ml	ml	CD	0
0.1	0.1	CD	0
%	%	NN	0
Triton	Triton	NNP	B-NP
X-100	X-100	NNP	I-NP
for	for	IN	0
determining	determining	VBG	0
the	the	DT	0
total	total	JJ	B-NP
cellular	cellular	JJ	I-NP
radioactivity	radioactivity	NN	I-NP
.	.	.	0
Authors	Authors	NNP	0
'	'	POS	0
contribution	contribution	NN	B-NP
JHE	JHE	VBP	0
carried	carried	VBN	0
out	out	RP	0
the	the	DT	0
Ca	Ca	NNP	B-NP
and	and	CC	0
fp	fp	NN	B-NP
imaging	imaging	NN	I-NP
study	study	NN	I-NP
,	,	,	0
participated	participated	VBD	0
in	in	IN	0
the	the	DT	0
design	design	NN	0
and	and	CC	0
coordination	coordination	NN	B-NP
of	of	IN	0
the	the	DT	0
study	study	NN	0
,	,	,	0
and	and	CC	0
drafted	drafted	VBD	0
the	the	DT	0
manuscript	manuscript	NN	0
.	.	.	0
DJF	DJF	NNP	B-NP
performed	performed	VBD	0
the	the	DT	0
AA	AA	NN	B-NP
release	release	NN	I-NP
and	and	CC	0
Western	Western	JJ	0
blot	blot	JJ	0
studies	studies	NNS	0
and	and	CC	0
participated	participated	VBD	0
in	in	IN	0
the	the	DT	0
design	design	NN	0
and	and	CC	0
coordination	coordination	NN	B-NP
of	of	IN	0
the	the	DT	0
study	study	NN	0
.	.	.	0
CCL	CCL	NNP	0
conceived	conceived	VBD	0
of	of	IN	0
the	the	DT	0
study	study	NN	0
,	,	,	0
participated	participated	VBD	0
in	in	IN	0
its	its	PRP$	0
design	design	NN	0
and	and	CC	0
coordination	coordination	NN	B-NP
,	,	,	0
and	and	CC	0
participated	participated	VBD	0
in	in	IN	0
writing	writing	VBG	0
the	the	DT	0
draft	draft	NN	0
.	.	.	0
All	All	DT	0
authors	authors	NNS	0
read	read	VBP	0
and	and	CC	0
approved	approved	VBD	0
the	the	DT	0
final	final	JJ	B-NP
manuscript	manuscript	NN	I-NP
.	.	.	0
